Direct	O
interaction	O
of	O
hematopoietic	B-protein
transcription	I-protein
factors	I-protein
PU.1	I-protein
and	I-protein
GATA-1	I-protein
:	O
functional	O
antagonism	O
in	O
erythroid	B-cell_type
cells	I-cell_type
.	O

Malignant	O
transformation	O
usually	O
inhibits	O
terminal	O
cell	O
differentiation	O
but	O
the	O
precise	O
mechanisms	O
involved	O
are	O
not	O
understood	O
.	O

PU.1	B-protein
is	O
a	O
hematopoietic-specific	B-protein
Ets	I-protein
family	I-protein
transcription	I-protein
factor	I-protein
that	O
is	O
required	O
for	O
development	O
of	O
some	O
lymphoid	B-cell_type
and	I-cell_type
myeloid	I-cell_type
lineages	I-cell_type
.	O

PU.1	B-protein
can	O
also	O
act	O
as	O
an	O
oncoprotein	B-protein
as	O
activation	O
of	O
its	O
expression	O
in	O
erythroid	O
precursors	O
by	O
proviral	O
insertion	O
or	O
transgenesis	O
causes	O
erythroleukemias	O
in	O
mice	O
.	O

Restoration	O
of	O
terminal	O
differentiation	O
in	O
the	O
mouse	B-cell_line
erythroleukemia	I-cell_line
(	I-cell_line
MEL	I-cell_line
)	I-cell_line
cells	I-cell_line
requires	O
a	O
decline	O
in	O
the	O
level	O
of	O
PU.1	B-protein
,	O
indicating	O
that	O
PU.1	B-protein
can	O
block	O
erythroid	O
differentiation	O
.	O

Here	O
we	O
investigate	O
the	O
mechanism	O
by	O
which	O
PU.1	B-protein
interferes	O
with	O
erythroid	O
differentiation	O
.	O

We	O
find	O
that	O
PU.1	B-protein
interacts	O
directly	O
with	O
GATA-1	B-protein
,	O
a	O
zinc	B-protein
finger	I-protein
transcription	I-protein
factor	I-protein
required	O
for	O
erythroid	O
differentiation	O
.	O

Interaction	O
between	O
PU.1	B-protein
and	O
GATA-1	B-protein
requires	O
intact	O
DNA-binding	B-protein
domains	I-protein
in	O
both	O
proteins	O
.	O

PU.1	B-protein
represses	O
GATA-1	B-protein
-mediated	O
transcriptional	O
activation	O
.	O

Both	O
the	O
DNA	B-protein
binding	I-protein
and	O
transactivation	B-protein
domains	I-protein
of	O
PU.1	B-protein
are	O
required	O
for	O
repression	O
and	O
both	O
domains	O
are	O
also	O
needed	O
to	O
block	O
terminal	O
differentiation	O
in	O
MEL	B-cell_line
cells	I-cell_line
.	O

We	O
also	O
show	O
that	O
ectopic	O
expression	O
of	O
PU.1	B-protein
in	O
Xenopus	O
embryos	O
is	O
sufficient	O
to	O
block	O
erythropoiesis	O
during	O
normal	O
development	O
.	O

Furthermore	O
,	O
introduction	O
of	O
exogenous	O
GATA-1	B-protein
in	O
both	O
MEL	B-cell_line
cells	I-cell_line
and	O
Xenopus	O
embryos	O
and	O
explants	O
relieves	O
the	O
block	O
to	O
erythroid	O
differentiation	O
imposed	O
by	O
PU.1	B-protein
.	O

Our	O
results	O
indicate	O
that	O
the	O
stoichiometry	O
of	O
directly	O
interacting	O
but	O
opposing	O
transcription	B-protein
factors	I-protein
may	O
be	O
a	O
crucial	O
determinant	O
governing	O
processes	O
of	O
normal	O
differentiation	O
and	O
malignant	O
transformation	O
.	O

Direct	NULL
interaction	NULL
of	NULL
hematopoietic	NULL
transcription	NULL
factors	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
:	NULL
functional	NULL
antagonism	NULL
in	NULL
erythroid	NULL
cells	NULL
Natasha	NULL
Rekhtman	NULL
,	NULL
'	NULL
Farshid	NULL
Radparvar	NULL
,	NULL
'	NULL
Todd	NULL
Evans	NULL
,	NULL
``	NULL
and	NULL
Arthur	NULL
I.	NULL
Skoultchi'*	NULL
Departments	NULL
of	NULL
'Cell	NULL
Biology	NULL
and	NULL
*Developmental	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Albert	NULL
Einstein	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Bronx	NULL
,	NULL
New	NULL
York	NULL
10461	NULL
USA	NULL
Malignant	NULL
transformation	NULL
usually	NULL
inhibits	NULL
terminal	NULL
cell	NULL
differentiation	NULL
but	NULL
the	NULL
precise	NULL
mechanisms	NULL
involved	NULL
are	NULL
not	NULL
understood	NULL
.	NULL

PU.1	NULL
is	NULL
a	NULL
hematopoietic-specific	NULL
Ets	NULL
family	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
required	NULL
for	NULL
development	NULL
of	NULL
some	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
lineages	NULL
.	NULL

PU.1	NULL
can	NULL
also	NULL
act	NULL
as	NULL
an	NULL
oncoprotein	NULL
as	NULL
activation	NULL
of	NULL
its	NULL
expression	NULL
in	NULL
erythroid	NULL
precursors	NULL
by	NULL
proviral	NULL
insertion	NULL
or	NULL
transgenesis	NULL
causes	NULL
erythroleukemias	NULL
in	NULL
mice	NULL
.	NULL

Restoration	NULL
of	NULL
terminal	NULL
differentiation	NULL
in	NULL
the	NULL
mouse	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cells	NULL
requires	NULL
a	NULL
decline	NULL
in	NULL
the	NULL
level	NULL
of	NULL
PU.1	NULL
,	NULL
indicating	NULL
that	NULL
PU.1	NULL
can	NULL
block	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Here	NULL
we	NULL
investigate	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
PU.1	NULL
interferes	NULL
with	NULL
erythroid	NULL
differentiation	NULL
.	NULL

We	NULL
find	NULL
that	NULL
PU.1	NULL
interacts	NULL
directly	NULL
with	NULL
GATA-1	NULL
,	NULL
a	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Interaction	NULL
between	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
requires	NULL
intact	NULL
DNA-binding	NULL
domains	NULL
in	NULL
both	NULL
proteins	NULL
.	NULL

PU.1	NULL
represses	NULL
GATA-1-mediated	NULL
transcriptional	NULL
activation	NULL
.	NULL

Both	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
domains	NULL
of	NULL
PU.1	NULL
are	NULL
required	NULL
for	NULL
repression	NULL
and	NULL
both	NULL
domains	NULL
are	NULL
also	NULL
needed	NULL
to	NULL
block	NULL
terminal	NULL
differentiation	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
PU.1	NULL
in	NULL
Xenopus	NULL
embryos	NULL
is	NULL
sufficient	NULL
to	NULL
block	NULL
erythropoiesis	NULL
during	NULL
normal	NULL
development	NULL
.	NULL

Furthermore	NULL
,	NULL
introduction	NULL
of	NULL
exogenous	NULL
GATA-1	NULL
in	NULL
both	NULL
MEL	NULL
cells	NULL
and	NULL
Xenopus	NULL
embryos	NULL
and	NULL
explants	NULL
relieves	NULL
the	NULL
block	NULL
to	NULL
erythroid	NULL
differentiation	NULL
imposed	NULL
by	NULL
PU.1	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
stoichiometry	NULL
of	NULL
directly	NULL
interacting	NULL
but	NULL
opposing	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
a	NULL
crucial	NULL
determinant	NULL
governing	NULL
processes	NULL
of	NULL
normal	NULL
differentiation	NULL
and	NULL
malignant	NULL
transformation	NULL
.	NULL

[	NULL
Key	NULL
Words	NULL
:	NULL
PU.1	NULL
;	NULL
GATA-1	NULL
;	NULL
erythropoiesis	NULL
;	NULL
murine	NULL
erythroleukemia	NULL
;	NULL
differentiation	NULL
]	NULL
Received	NULL
January	NULL
25	NULL
,	NULL
1999	NULL
;	NULL
revised	NULL
version	NULL
accepted	NULL
April	NULL
19	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
hallmark	NULL
features	NULL
of	NULL
many	NULL
cancers	NULL
include	NULL
both	NULL
a	NULL
loss	NULL
of	NULL
normal	NULL
proliferation	NULL
controls	NULL
and	NULL
a	NULL
block	NULL
to	NULL
differentiation	NULL
(	NULL
Hunter	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
study	NULL
of	NULL
oncogenic	NULL
viruses	NULL
and	NULL
the	NULL
genetic	NULL
lesions	NULL
present	NULL
in	NULL
animal	NULL
and	NULL
human	NULL
cancers	NULL
has	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
oncoproteins	NULL
and	NULL
tumor	NULL
suppressor	NULL
proteins	NULL
and	NULL
an	NULL
increasingly	NULL
deep	NULL
understanding	NULL
of	NULL
how	NULL
these	NULL
proteins	NULL
regulate	NULL
cell	NULL
prolif-eration	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
we	NULL
know	NULL
less	NULL
about	NULL
how	NULL
malignant	NULL
transformation	NULL
affects	NULL
the	NULL
genes	NULL
and	NULL
gene	NULL
products	NULL
that	NULL
regulate	NULL
cell	NULL
differentiation	NULL
.	NULL

Very	NULL
fre-quently	NULL
,	NULL
leukemogenesis	NULL
in	NULL
humans	NULL
and	NULL
mice	NULL
is	NULL
associated	NULL
with	NULL
alterations	NULL
in	NULL
the	NULL
structure	NULL
or	NULL
regulation	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
participate	NULL
in	NULL
normal	NULL
blood	NULL
cell	NULL
development	NULL
(	NULL
Look	NULL
1997	NULL
;	NULL
Tenen	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Such	NULL
events	NULL
often	NULL
exhibit	NULL
a	NULL
very	NULL
high	NULL
degree	NULL
of	NULL
specificity	NULL
for	NULL
a	NULL
particular	NULL
hematopoietic	NULL
lineage	NULL
and	NULL
stage	NULL
of	NULL
differentiation	NULL
,	NULL
but	NULL
the	NULL
molecular	NULL
mechanisms	NULL
leading	NULL
to	NULL
specific	NULL
differentiation	NULL
blockades	NULL
are	NULL
not	NULL
understood	NULL
.	NULL

Friend	NULL
virus-induced	NULL
erythroleukemias	NULL
of	NULL
mice	NULL
have	NULL
served	NULL
as	NULL
an	NULL
important	NULL
model	NULL
for	NULL
studying	NULL
the	NULL
multistep	NULL
*Corresponding	NULL
author	NULL
.	NULL

E-MAIL	NULL
skoultch	NULL
@	NULL
aecom.yu.edu	NULL
;	NULL
FAX	NULL
(	NULL
718	NULL
)	NULL
430-8574.	NULL
process	NULL
of	NULL
leukemia	NULL
development	NULL
(	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
1991	NULL
)	NULL
.	NULL

Likewise	NULL
the	NULL
in	NULL
vitro	NULL
terminal	NULL
differentiation	NULL
that	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
the	NULL
permanent	NULL
murine	NULL
erythroleukemia	NULL
{	NULL
(	NULL
MEL	NULL
)	NULL
cell	NULL
lines	NULL
established	NULL
from	NULL
such	NULL
mice	NULL
(	NULL
Marks	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
has	NULL
stimulated	NULL
interest	NULL
in	NULL
approaches	NULL
to	NULL
cancer	NULL
therapy	NULL
based	NULL
on	NULL
forced	NULL
differentiation	NULL
of	NULL
tumor	NULL
cells	NULL
.	NULL

Friend	NULL
virus	NULL
consists	NULL
of	NULL
a	NULL
complex	NULL
of	NULL
two	NULL
ret-roviruses	NULL
:	NULL
the	NULL
replication-defective	NULL
spleen-focus-forming	NULL
virus	NULL
{	NULL
SFFV	NULL
)	NULL
and	NULL
a	NULL
replication-competent	NULL
,	NULL
helper	NULL
Friend	NULL
murine	NULL
leukemia	NULL
virus	NULL
(	NULL
F-MuLV	NULL
)	NULL
.	NULL

There	NULL
are	NULL
at	NULL
least	NULL
three	NULL
events	NULL
that	NULL
contribute	NULL
to	NULL
generation	NULL
of	NULL
malignant	NULL
erythroid	NULL
cells	NULL
in	NULL
Friend	NULL
virus-infected	NULL
mice	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
early	NULL
stage	NULL
of	NULL
the	NULL
disease	NULL
is	NULL
characterized	NULL
by	NULL
polyclonal	NULL
proliferation	NULL
of	NULL
nonleukemic	NULL
erythroid	NULL
progenitors	NULL
caused	NULL
by	NULL
interaction	NULL
of	NULL
the	NULL
SFFV-encoded	NULL
55-kd	NULL
fusion	NULL
glycoprotein	NULL
(	NULL
gp	NULL
55	NULL
)	NULL
with	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
,	NULL
triggering	NULL
constitu-tive	NULL
activation	NULL
of	NULL
mitogenic	NULL
signaling	NULL
.	NULL

The	NULL
subsequent	NULL
emergence	NULL
of	NULL
clonal	NULL
or	NULL
oligoclonal	NULL
malignant	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
two	NULL
additional	NULL
genetic	NULL
events	NULL
:	NULL
inactivation	NULL
of	NULL
p53	NULL
and	NULL
SFFV	NULL
proviral	NULL
insertions	NULL
at	NULL
the	NULL
Spi-1	NULL
locus	NULL
that	NULL
encodes	NULL
the	NULL
PU.1	NULL
transcription	NULL
factor	NULL
(	NULL
Moreau	NULL
Gachelin	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
;	NULL
Paul	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
;	NULL
Goebl	NULL
1990	NULL
)	NULL
.	NULL

Inte-	NULL
1398	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
13:1398-1411	NULL
©	NULL
1999	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
ISSN	NULL
0890-9369/99	NULL
$	NULL
5.00	NULL
;	NULL
www.genesdev.org	NULL
gration	NULL
of	NULL
SFFV	NULL
does	NULL
not	NULL
disrupt	NULL
PU.1	NULL
gene	NULL
expression	NULL
;	NULL
rather	NULL
it	NULL
is	NULL
thought	NULL
to	NULL
activate	NULL
or	NULL
deregulate	NULL
PU.1	NULL
synthesis	NULL
in	NULL
erythroid	NULL
precursors	NULL
(	NULL
Moreau-Gachelin	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Proof	NULL
that	NULL
PU.1	NULL
plays	NULL
a	NULL
causative	NULL
role	NULL
in	NULL
erythro-leukemogenesis	NULL
came	NULL
from	NULL
the	NULL
observation	NULL
that	NULL
transgenic	NULL
mice	NULL
expressing	NULL
PU.1	NULL
in	NULL
erythroid	NULL
cells	NULL
develop	NULL
erythroleukemias	NULL
at	NULL
a	NULL
high	NULL
rate	NULL
(	NULL
Moreau-Gachelin	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Its	NULL
role	NULL
in	NULL
transformation	NULL
of	NULL
erythroid	NULL
cells	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
finding	NULL
that	NULL
a	NULL
PU.l-encoding	NULL
retrovi-rus	NULL
can	NULL
immortalize	NULL
erythroblasts	NULL
efficiently	NULL
from	NULL
infected	NULL
long-term	NULL
bone	NULL
marrow	NULL
cultures	NULL
(	NULL
Schuetze	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

PU.1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Interestingly	NULL
,	NULL
two	NULL
other	NULL
ets	NULL
family	NULL
genes	NULL
,	NULL
fli-1	NULL
and	NULL
v-ets	NULL
have	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
erythroleu-kemic	NULL
transformation	NULL
(	NULL
Ben-David	NULL
and	NULL
Bernstein	NULL
1991	NULL
)	NULL
.	NULL

PU.1	NULL
is	NULL
expressed	NULL
specifically	NULL
in	NULL
hematopoietic	NULL
tis-sues	NULL
,	NULL
with	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
mono-cytic	NULL
,	NULL
granulocytic	NULL
and	NULL
B	NULL
lymphoid	NULL
lineages	NULL
(	NULL
Galson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Hromas	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

A	NULL
large	NULL
number	NULL
of	NULL
presumptive	NULL
PU.1	NULL
target	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
Fisher	NULL
and	NULL
Scott	NULL
1998	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
expressed	NULL
in	NULL
myeloid	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
including	NULL
some	NULL
that	NULL
are	NULL
thought	NULL
to	NULL
have	NULL
important	NULL
roles	NULL
in	NULL
differentiation	NULL
and	NULL
survival	NULL
of	NULL
cells	NULL
within	NULL
these	NULL
lineages	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
view	NULL
,	NULL
inactivation	NULL
of	NULL
the	NULL
PU.1	NULL
gene	NULL
in	NULL
mice	NULL
causes	NULL
defects	NULL
in	NULL
the	NULL
development	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
,	NULL
including	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
granulo-cytes	NULL
[	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
;	NULL
McKercher	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

PU.1	NULL
probably	NULL
plays	NULL
important	NULL
roles	NULL
at	NULL
several	NULL
stages	NULL
of	NULL
the	NULL
differentiation	NULL
process	NULL
,	NULL
and	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
it	NULL
is	NULL
active	NULL
at	NULL
an	NULL
early	NULL
stage	NULL
,	NULL
mediating	NULL
commitment	NULL
of	NULL
multipotent	NULL
progenitors	NULL
to	NULL
the	NULL
myeloid	NULL
lineage	NULL
(	NULL
Nerlov	NULL
and	NULL
Graf	NULL
1998	NULL
)	NULL
.	NULL

However	NULL
,	NULL
PU.1	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
needed	NULL
for	NULL
production	NULL
of	NULL
megakaryocytes	NULL
or	NULL
erythrocytes	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
differentiation	NULL
that	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
permanent	NULL
MEL	NULL
cell	NULL
lines	NULL
established	NULL
from	NULL
Friend	NULL
virus-infected	NULL
mice	NULL
provides	NULL
an	NULL
opportunity	NULL
to	NULL
analyze	NULL
events	NULL
occurring	NULL
when	NULL
the	NULL
leukemic	NULL
phenotype	NULL
is	NULL
reversed	NULL
and	NULL
the	NULL
cells	NULL
reenter	NULL
their	NULL
erythroid	NULL
differentiation	NULL
program	NULL
(	NULL
Marks	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

MEL	NULL
cells	NULL
are	NULL
transformed	NULL
erythroid	NULL
precursors	NULL
that	NULL
are	NULL
blocked	NULL
at	NULL
about	NULL
the	NULL
proerythroblast	NULL
stage	NULL
of	NULL
differentiation	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
agents	NULL
causes	NULL
them	NULL
to	NULL
undergo	NULL
differentiation	NULL
over	NULL
several	NULL
days	NULL
and	NULL
culminates	NULL
in	NULL
terminal	NULL
cell	NULL
division	NULL
and	NULL
accumulation	NULL
of	NULL
hemoglobin	NULL
and	NULL
other	NULL
eryth-rocyte-specific	NULL
proteins	NULL
.	NULL

One	NULL
of	NULL
the	NULL
early	NULL
events	NULL
occurring	NULL
during	NULL
this	NULL
process	NULL
is	NULL
a	NULL
marked	NULL
decline	NULL
in	NULL
levels	NULL
of	NULL
PU.1	NULL
{	NULL
Schuetze	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
;	NULL
Galson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
may	NULL
block	NULL
erythroid	NULL
differentiation	NULL
.	NULL

By	NULL
transfecting	NULL
MEL	NULL
cells	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
PU.1	NULL
we	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
and	NULL
other	NULL
investigators	NULL
[	NULL
Yamada	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
PU.1	NULL
can	NULL
indeed	NULL
block	NULL
erythroid	NULL
differentiation	NULL
of	NULL
MEL	NULL
cells	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PU.1	NULL
on	NULL
erythroid	NULL
differentiation	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
other	NULL
cell	NULL
culture	NULL
models	NULL
{	NULL
Quang	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Delgado	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
)	NULL
.	NULL

An	NULL
intriguing	NULL
aspect	NULL
of	NULL
the	NULL
block	NULL
to	NULL
differentiation	NULL
in	NULL
MEL	NULL
cells	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
cells	NULL
contain	NULL
substantial	NULL
amounts	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
erythroid	NULL
differentiation	NULL
,	NULL
including	NULL
GATA-1	NULL
,	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
eryth-	NULL
Interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
ropoiesis	NULL
and	NULL
expression	NULL
of	NULL
most	NULL
erythroid-specific	NULL
genes	NULL
(	NULL
Shivdasasani	NULL
and	NULL
Orkin	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
PU.1	NULL
binds	NULL
directly	NULL
to	NULL
GATA-1	NULL
and	NULL
specifically	NULL
inhibits	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
reporter	NULL
genes	NULL
.	NULL

Moreover	NULL
we	NULL
show	NULL
that	NULL
the	NULL
stoichiometry	NULL
of	NULL
PU.l1	NULL
and	NULL
GATA-1	NULL
affects	NULL
erythroid	NULL
differentiation	NULL
capacity	NULL
in	NULL
MEL	NULL
cells	NULL
and	NULL
Xenopus	NULL
embryos	NULL
and	NULL
explants	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
PU.1	NULL
blocks	NULL
differentiation	NULL
in	NULL
erythroleukemia	NULL
cells	NULL
and	NULL
contributes	NULL
to	NULL
leukemogenesis	NULL
by	NULL
binding	NULL
to	NULL
and	NULL
inhibiting	NULL
the	NULL
ability	NULL
of	NULL
GATA-1	NULL
to	NULL
promote	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
.	NULL

We	NULL
also	NULL
discuss	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
opposing	NULL
actions	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
or	NULL
other	NULL
GATA	NULL
factors	NULL
contributes	NULL
to	NULL
lineage	NULL
determination	NULL
during	NULL
normal	NULL
hematopoiesis	NULL
.	NULL

Results	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
interact	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
As	NULL
mentioned	NULL
above	NULL
,	NULL
several	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
erythroid	NULL
differentiation	NULL
are	NULL
present	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

These	NULL
factors	NULL
include	NULL
GATA-1	NULL
(	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
;	NULL
Leonard	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
,	NULL
erythroid	NULL
Kriippel-like	NULL
factor	NULL
{	NULL
[	NULL
EKLF	NULL
;	NULL
Miller	NULL
and	NULL
Bieker	NULL
1993	NULL
)	NULL
,	NULL
p45	NULL
NF-E2	NULL
(	NULL
Lu	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
,	NULL
and	NULL
Friend	NULL
of	NULL
GATA-1	NULL
{	NULL
[	NULL
FOG	NULL
;	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Restoration	NULL
of	NULL
terminal	NULL
differentiation	NULL
in	NULL
MEL	NULL
cells	NULL
requires	NULL
a	NULL
large	NULL
decrease	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
PU.1	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
PU.1	NULL
might	NULL
interact	NULL
directly	NULL
with	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
and	NULL
inhibit	NULL
their	NULL
activities	NULL
in	NULL
promoting	NULL
differentiation	NULL
.	NULL

We	NULL
examined	NULL
potential	NULL
in	NULL
vitro	NULL
interactions	NULL
between	NULL
PU.1	NULL
and	NULL
these	NULL
factors	NULL
by	NULL
using	NULL
GST-PU.1	NULL
immobilized	NULL
on	NULL
glutathione-Sepharose	NULL
beads	NULL
and	NULL
in	NULL
vitro	NULL
synthesized	NULL
5°S-labeled	NULL
proteins	NULL
.	NULL

About	NULL
15	NULL
%	NULL
of	NULL
input	NULL
GATA-1l	NULL
bound	NULL
to	NULL
GST-PU.1	NULL
,	NULL
whereas	NULL
GATA-1	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
immobilized	NULL
GST	NULL
{	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
very	NULL
little	NULL
EKLF	NULL
was	NULL
bound	NULL
to	NULL
GST-PU.1	NULL
and	NULL
binding	NULL
of	NULL
p45	NULL
NF-E2	NULL
or	NULL
FOG	NULL
to	NULL
GST-PU.1	NULL
was	NULL
not	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

A	NULL
strong	NULL
interaction	NULL
was	NULL
also	NULL
evident	NULL
when	NULL
GST-GATA-1	NULL
and	NULL
°°S-labeled	NULL
PU.1	NULL
were	NULL
used	NULL
,	NULL
whereas	NULL
PU.1	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
GST	NULL
nor	NULL
to	NULL
another	NULL
GST	NULL
fusion	NULL
protein	NULL
,	NULL
GST-GUK	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
occurs	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
%	NULL
NP-40	NULL
(	NULL
{	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
°°S-labeled	NULL
proteins	NULL
used	NULL
in	NULL
binding	NULL
reactions	NULL
were	NULL
synthesized	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysates	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
PU.1-GATA-1	NULL
interaction	NULL
is	NULL
direct	NULL
or	NULL
dependent	NULL
on	NULL
a	NULL
bridging	NULL
molecule	NULL
that	NULL
might	NULL
be	NULL
present	NULL
in	NULL
the	NULL
lysate	NULL
.	NULL

Interaction	NULL
is	NULL
direct	NULL
because	NULL
PU.1-GATA-1	NULL
complexes	NULL
were	NULL
formed	NULL
using	NULL
both	NULL
molecules	NULL
purified	NULL
from	NULL
bacteria	NULL
(	NULL
Fig.1B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
formation	NULL
of	NULL
PU.1-GATA-1	NULL
complexes	NULL
was	NULL
unaffected	NULL
by	NULL
ethidium	NULL
bromide	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
interaction	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
contaminating	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
complexes	NULL
form	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
transfected	NULL
expression	NULL
vectors	NULL
encoding	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
into	NULL
293	NULL
cells	NULL
and	NULL
analyzed	NULL
nuclear	NULL
extracts	NULL
for	NULL
PU.1-GATA-1	NULL
complexes	NULL
by	NULL
immunoprecipitating	NULL
with	NULL
an	NULL
anti-GATA-1	NULL
antibody	NULL
and	NULL
immunoblotting	NULL
for	NULL
PU.1	NULL
.	NULL

PU.1-GATA-1	NULL
complexes	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
transfected	NULL
cell	NULL
extracts	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
PU.1	NULL
in	NULL
the	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1399	NULL
Rekhtman	NULL
et	NULL
al	NULL
.	NULL

A	NULL
___	NULL
_GATAL	NULL
EKLE	NULL
p45	NULL
NF-E2	NULL
FOG	NULL
1	NULL
3	NULL
1	NULL
3	NULL
1°	NULL
5s	NULL
no	NULL
3	NULL
2	NULL
5.	NULL
eal	NULL
a	NULL
.	NULL

D	NULL
=	NULL
``	NULL
-	NULL
c.	NULL
B	NULL
C	NULL
A	NULL
S	NULL
A	NULL
~	NULL
S	NULL
B	NULL
2	NULL
Eo	NULL
Boos	NULL
Eo	NULL
Bee	NULL
=-	NULL
bo	NULL
Ao	NULL
Bog	NULL
m	NULL
t	NULL
2	NULL
m	NULL
m	NULL
2	NULL
t	NULL
wm	NULL
2	NULL
mo	NULL
te	NULL
|	NULL
9	NULL
9	NULL
2	NULL
p	NULL
9	NULL
2	NULL
o	NULL
u	NULL
2	NULL
9	NULL
9	NULL
2	NULL
a	NULL
~a	NULL
HHB	NULL
ac	NULL
.	NULL

<	NULL
Ws	NULL
B	NULL
PU.1	NULL
GATA-I	NULL
C	NULL
pl	NULL
GATA-1	NULL
4	NULL
l_	NULL
a	NULL
e	NULL
5	NULL
8	NULL
.	NULL

OE	NULL
-	NULL
3	NULL
Ce	NULL
e	NULL
&	NULL
R	NULL
,	NULL
.	NULL

5	NULL
Eo	NULL
B	NULL
s	NULL
bob	NULL
org	NULL
Eo	NULL
B	NULL
mG	NULL
oe	NULL
w	NULL
u	NULL
i	NULL
>	NULL
w	NULL
w	NULL
ir	NULL
w	NULL
u	NULL
u	NULL
>	NULL
ace	NULL
0	NULL
$	NULL
S4	NULL
?	NULL
}	NULL

@	NULL
a	NULL
-	NULL
:	NULL
--	NULL
-	NULL
q	NULL
<	NULL
Western	NULL
0	NULL
.	NULL

PU.1	NULL
Western	NULL
0	NULL
.	NULL

GATA-1	NULL
Figure	NULL
1	NULL
.	NULL

PU.1	NULL
and	NULL
GATA-1	NULL
interact	NULL
in	NULL
vitro	NULL
.	NULL

(	NULL
A	NULL
)	NULL
°°S-Labeled	NULL
proteins	NULL
,	NULL
indicated	NULL
above	NULL
each	NULL
panel	NULL
,	NULL
were	NULL
prepared	NULL
and	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
GST	NULL
or	NULL
GST-PU.1	NULL
by	NULL
a	NULL
'pull-down	NULL
'	NULL
assay	NULL
using	NULL
proteins	NULL
immobilized	NULL
on	NULL
glutathione-Sepharose	NULL
beads	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
released	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
.	NULL

An	NULL
autora-diogram	NULL
of	NULL
10	NULL
%	NULL
of	NULL
each	NULL
°°S-labeled	NULL
protein	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
is	NULL
shown	NULL
in	NULL
each	NULL
panel	NULL
{	NULL
10	NULL
%	NULL
input	NULL
)	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
the	NULL
S-labeled	NULL
proteins	NULL
on	NULL
the	NULL
gel	NULL
.	NULL

{	NULL
B	NULL
]	NULL
PU.1	NULL
or	NULL
GATA-1	NULL
,	NULL
as	NULL
indicated	NULL
above	NULL
each	NULL
panel	NULL
,	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
respective	NULL
GST	NULL
fusion	NULL
proteins	NULL
by	NULL
thrombin	NULL
cleavage	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

The	NULL
purified	NULL
proteins	NULL
were	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
GST	NULL
,	NULL
GST-GATA-1	NULL
or	NULL
GST-PU.1	NULL
by	NULL
a	NULL
pull-down	NULL
assay	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
.	NULL

An	NULL
immunoblot	NULL
of	NULL
25	NULL
%	NULL
of	NULL
the	NULL
purified	NULL
PU.1	NULL
or	NULL
GATA-1	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
is	NULL
shown	NULL
in	NULL
each	NULL
panel	NULL
{	NULL
25	NULL
%	NULL
Input	NULL
)	NULL
.	NULL

{	NULL
C	NULL
)	NULL
As	NULL
in	NULL
A	NULL
except	NULL
that	NULL
where	NULL
indicated	NULL
100	NULL
ug/ml	NULL
of	NULL
ethidium	NULL
bromide	NULL
{	NULL
EtBr	NULL
]	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

anti-GATA-1	NULL
immunoprecipitate	NULL
was	NULL
dependent	NULL
on	NULL
co-transfection	NULL
of	NULL
both	NULL
expression	NULL
vectors	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

MEL	NULL
cell	NULL
extracts	NULL
were	NULL
also	NULL
analyzed	NULL
by	NULL
coimmunoprecipita-tion	NULL
experiments	NULL
,	NULL
using	NULL
both	NULL
anti-GATA-1	NULL
and	NULL
anti-PU.1	NULL
antibodies	NULL
to	NULL
determine	NULL
whether	NULL
endogenous	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
are	NULL
associated	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

PU.1-GATA-1	NULL
complexes	NULL
were	NULL
readily	NULL
detected	NULL
in	NULL
MEL	NULL
cell	NULL
nuclear	NULL
extracts	NULL
using	NULL
either	NULL
antibody	NULL
,	NULL
whereas	NULL
the	NULL
association	NULL
was	NULL
not	NULL
seen	NULL
when	NULL
control	NULL
antibodies	NULL
were	NULL
used	NULL
{	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

We	NULL
estimate	NULL
that	NULL
a	NULL
large	NULL
fraction	NULL
of	NULL
GATA-1	NULL
is	NULL
bound	NULL
to	NULL
PU.1	NULL
in	NULL
the	NULL
tumor	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
interaction	NULL
may	NULL
be	NULL
important	NULL
in	NULL
the	NULL
PU.1-mediated	NULL
block	NULL
to	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

PU.1	NULL
targets	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
of	NULL
GATA-1	NULL
To	NULL
define	NULL
the	NULL
regions	NULL
within	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
that	NULL
are	NULL
required	NULL
for	NULL
interaction	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
,	NULL
we	NULL
tested	NULL
a	NULL
set	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
each	NULL
protein	NULL
for	NULL
their	NULL
abilities	NULL
to	NULL
interact	NULL
in	NULL
vitro	NULL
.	NULL

Structure-function	NULL
studies	NULL
of	NULL
both	NULL
proteins	NULL
have	NULL
delineated	NULL
specific	NULL
regions	NULL
or	NULL
domains	NULL
that	NULL
contribute	NULL
to	NULL
their	NULL
functions	NULL
as	NULL
transcription	NULL
factors	NULL
as	NULL
well	NULL
as	NULL
their	NULL
interactions	NULL
with	NULL
other	NULL
proteins	NULL
.	NULL

1400	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
GATA-1	NULL
binding	NULL
to	NULL
DNA	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
domain	NULL
comprised	NULL
of	NULL
two	NULL
zinc	NULL
fingers	NULL
.	NULL

The	NULL
carboxy-terminal	NULL
finger	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
whereas	NULL
the	NULL
amino-terminal	NULL
finger	NULL
is	NULL
thought	NULL
to	NULL
stabilize	NULL
binding	NULL
(	NULL
Martin	NULL
and	NULL
Orkin	NULL
1990	NULL
)	NULL
.	NULL

Both	NULL
fingers	NULL
have	NULL
been	NULL
found	NULL
to	NULL
interact	NULL
with	NULL
other	NULL
proteins	NULL
(	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
and	NULL
references	NULL
therein	NULL
}	NULL
.	NULL

Transfection	NULL
assays	NULL
have	NULL
defined	NULL
several	NULL
regions	NULL
of	NULL
GATA-1	NULL
contributing	NULL
to	NULL
transcriptional	NULL
trans-activation	NULL
,	NULL
the	NULL
most	NULL
potent	NULL
of	NULL
which	NULL
lies	NULL
near	NULL
the	NULL
amino-terminal	NULL
end	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
Martin	NULL
and	NULL
Orkin	NULL
1990	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
finger	NULL
region	NULL
was	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
interaction	NULL
with	NULL
PU.1	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
B	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
region	NULL
encoding	NULL
both	NULL
fingers	NULL
of	NULL
GATA-1	NULL
abolished	NULL
completely	NULL
the	NULL
interaction	NULL
,	NULL
and	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
comprising	NULL
only	NULL
the	NULL
finger	NULL
region	NULL
of	NULL
GATA-1	NULL
bound	NULL
PU.1	NULL
quite	NULL
well	NULL
.	NULL

Other	NULL
regions	NULL
in	NULL
GATA-1	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
interaction	NULL
as	NULL
the	NULL
extent	NULL
of	NULL
binding	NULL
of	NULL
PU.1	NULL
to	NULL
the	NULL
GST	NULL
fingers	NULL
fusion	NULL
protein	NULL
was	NULL
less	NULL
than	NULL
to	NULL
full-length	NULL
GST-GATA-1	NULL
.	NULL

Within	NULL
the	NULL
GATA-1	NULL
finger	NULL
region	NULL
both	NULL
the	NULL
amino-terminal	NULL
finger	NULL
and	NULL
the	NULL
carboxy-terminal	NULL
finger	NULL
appear	NULL
to	NULL
contribute	NULL
to	NULL
binding	NULL
to	NULL
PU.l1	NULL
as	NULL
GATA-1	NULL
proteins	NULL
containing	NULL
a	NULL
deletion	NULL
of	NULL
either	NULL
finger	NULL
or	NULL
a	NULL
substitution	NULL
of	NULL
two	NULL
cysteines	NULL
that	NULL
disrupt	NULL
the	NULL
carboxyl	NULL
finger	NULL
(	NULL
disrC	NULL
)	NULL
bind	NULL
less	NULL
well	NULL
to	NULL
PU.1	NULL
than	NULL
full-length	NULL
GATA-1	NULL
[	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
both	NULL
GATA-1	NULL
fingers	NULL
to	NULL
binding	NULL
to	NULL
PU.1	NULL
was	NULL
confirmed	NULL
by	NULL
coimmunopre-cipitaion	NULL
experiments	NULL
in	NULL
transfected	NULL
293	NULL
cells	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
results	NULL
,	NULL
deletion	NULL
of	NULL
both	NULL
fingers	NULL
abolished	NULL
the	NULL
interaction	NULL
,	NULL
whereas	NULL
GATA-l1	NULL
proteins	NULL
that	NULL
are	NULL
deleted	NULL
for	NULL
either	NULL
finger	NULL
bind	NULL
PU.1	NULL
in	NULL
vivo	NULL
but	NULL
with	NULL
an	NULL
apparent	NULL
reduced	NULL
affinity	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
GATA-1	NULL
fragment	NULL
comprising	NULL
only	NULL
the	NULL
carboxy-terminal	NULL
finger	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
GST-PU.1	NULL
[	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
by	NULL
PU.1	NULL
is	NULL
directed	NULL
by	NULL
the	NULL
carboxy-terminal	NULL
ets	NULL
homology	NULL
region	NULL
(	NULL
Klemsz	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
an	NULL
intact	NULL
DNA-binding	NULL
domain	NULL
,	NULL
transactivation	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
PU.1-binding	NULL
sites	NULL
requires	NULL
an	NULL
amino-terminal	NULL
region	NULL
consisting	NULL
of	NULL
acidic	NULL
and	NULL
glutamine-rich	NULL
subdomains	NULL
(	NULL
Klemsz	NULL
and	NULL
Maki	NULL
1996	NULL
and	NULL
references	NULL
therein	NULL
}	NULL
.	NULL

There	NULL
is	NULL
also	NULL
a	NULL
central	NULL
region	NULL
rich	NULL
in	NULL
proline	NULL
,	NULL
glutamic	NULL
acid	NULL
,	NULL
serine	NULL
,	NULL
and	NULL
threonine	NULL
{	NULL
(	NULL
PEST	NULL
)	NULL
residues	NULL
(	NULL
Moreau-Gachelin	NULL
1994	NULL
)	NULL
.	NULL

Certain	NULL
interactions	NULL
of	NULL
PU.1	NULL
with	NULL
other	NULL
proteins	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
transactivation	NULL
domain	NULL
(	NULL
Hagemeir	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
}	NULL
,	NULL
whereas	NULL
other	NULL
interactions	NULL
occur	NULL
with	NULL
the	NULL
Ets	NULL
domain	NULL
(	NULL
Nagulapalli	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Petrovick	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
PEST	NULL
region	NULL
or	NULL
deletions	NULL
encompassing	NULL
portions	NULL
of	NULL
the	NULL
amino-terminal	NULL
transactivation	NULL
domain	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
PU.1-GATA-1	NULL
interaction	NULL
in	NULL
vitro	NULL
[	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
D	NULL
)	NULL
.	NULL

These	NULL
deletions	NULL
also	NULL
did	NULL
not	NULL
affect	NULL
interaction	NULL
of	NULL
PU.l1	NULL
and	NULL
GATA-1	NULL
in	NULL
vivo	NULL
{	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
region	NULL
of	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
PU.1	NULL
abolished	NULL
completely	NULL
its	NULL
interaction	NULL
with	NULL
GATA-1	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
two	NULL
proteins	NULL
appear	NULL
to	NULL
interact	NULL
through	NULL
their	NULL
respective	NULL
DNA-binding	NULL
regions	NULL
.	NULL

GATA-1	NULL
is	NULL
highly	NULL
related	NULL
in	NULL
its	NULL
DNA-binding	NULL
zinc	NULL
finger	NULL
region	NULL
to	NULL
GATA-2	NULL
and	NULL
GATA-3	NULL
,	NULL
two	NULL
other	NULL
GATA	NULL
factors	NULL
involved	NULL
in	NULL
hematopoiesis	NULL
{	NULL
Shivdasani	NULL
and	NULL
Orkin	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
three	NULL
proteins	NULL
share	NULL
little	NULL
similarity	NULL
outside	NULL
of	NULL
the	NULL
finger	NULL
region	NULL
.	NULL

We	NULL
found	NULL
that	NULL
GATA-2	NULL
and	NULL
GATA-3	NULL
Interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
lo	NULL
3	NULL
A	NULL
IP	NULL
e-GATA-1	NULL
B	NULL
l	NULL
Transfected	NULL
i	NULL
T	NULL
3	NULL
GATAL	NULL
+0	NULL
-	NULL
0s	NULL
<	NULL
E	NULL
g	NULL
3	NULL
§	NULL
g	NULL
PUL	NULL
+	NULL
+0	NULL
&	NULL
9	NULL
$	NULL
£	NULL
*	NULL
$	NULL
E	NULL
Western	NULL
6027	NULL
Weste	NULL
PoP	NULL
_T	NULL
Weste	NULL
$	NULL
o	NULL
040	NULL
T	NULL
c	NULL
estern	NULL
wa	NULL
_	NULL
estern	NULL
Wei	NULL
-	NULL
lee	NULL
c-PU.1	NULL
wee	NULL
a	NULL
‘	NULL
o-PU.1	NULL
.	NULL

<	NULL
c-GATA-1	NULL
~a=	NULL
«	NULL
-GATAI	NULL
§§	NULL
eee	NULL
_	NULL
)	NULL
45	NULL
-	NULL
o-GATA-L	NULL
Q	NULL
«	NULL
tule	NULL
__	NULL
-	NULL
>	NULL
o-PU.1	NULL
q-	NULL
ye	NULL
C	NULL
IP	NULL
e-GATA-1	NULL
Input	NULL
D	NULL
IP	NULL
IP	NULL
IP	NULL
Toos	NULL
7oog	NULL
c-GATA-1	NULL
c-GATA-1	NULL
c-GATA-1	NULL
Transfected	NULL
ﬁ	NULL
3	NULL
ﬁ	NULL
&	NULL
Transfected	NULL
_	NULL
_	NULL
_	NULL
GATA-l-construct	NULL
|	NULL
<	NULL
&	NULL
Z	NULL
Y	NULL
<	NULL
E	NULL
z	NULL
y	NULL
GATAL	NULL
-	NULL
+	NULL
2	NULL
co	NULL
to	NULL
oc	NULL
t	NULL
£	NULL
0	NULL
<	NULL
4	NULL
<	NULL
4	NULL
4	NULL
|	NULL
09	NULL
<	NULL
4	NULL
<	NULL
4	NULL
<	NULL
-	NULL
PU.-construct	NULL
+	NULL
+	NULL
5	NULL
+	NULL
£	NULL
A	NULL
£	NULL
+	NULL
a	NULL
PU.1	NULL
to	NULL
t	NULL
+	NULL
+	NULL
f	NULL
+o	NULL
+	NULL
+	NULL
+	NULL
+	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
a	NULL
Westen	NULL
«	NULL
e	NULL
-	NULL
*	NULL
Westen	NULL
*	NULL
a-PU1	NULL
~-	NULL
Seema	NULL
.	NULL

#	NULL
-s	NULL
us	NULL
~	NULL
o-PU.1	NULL
--	NULL
«	NULL
n	NULL
«	NULL
cara	NULL
**	NULL
8	NULL
ap-	NULL
``	NULL
0	NULL
ap	NULL
-~	NULL
aB	NULL
ae	NULL
=	NULL
PU.1	NULL
PU	NULL
.	NULL

1-ATAD	NULL
PU	NULL
.	NULL

1-APEST	NULL
«	NULL
on	NULL
qe	NULL
go	NULL
re	NULL
me	NULL
an	NULL
«	NULL
ane	NULL
.	NULL

tts	NULL
~	NULL
&	NULL
-—.———	NULL
<	NULL
~=	NULL
)	NULL
'	NULL
Figure	NULL
2	NULL
.	NULL

PU.1	NULL
and	NULL
GATA-1	NULL
interact	NULL
in	NULL
vivo	NULL
.	NULL

{	NULL
A	NULL
]	NULL
Nuclear	NULL
extracts	NULL
from	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
PU.1	NULL
or	NULL
both	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
were	NULL
prepared	NULL
and	NULL
immunopreciptated	NULL
with	NULL
an	NULL
anti-GATA-1	NULL
antibody	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
.	NULL

An	NULL
immunoblot	NULL
of	NULL
15	NULL
%	NULL
of	NULL
the	NULL
amount	NULL
of	NULL
extract	NULL
that	NULL
was	NULL
immunoprecipitated	NULL
is	NULL
shown	NULL
{	NULL
Input	NULL
)	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
immunode-tected	NULL
proteins	NULL
.	NULL

The	NULL
asterisked	NULL
{	NULL
*	NULL
]	NULL
arrowhead	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
Ig	NULL
chains	NULL
,	NULL
which	NULL
are	NULL
used	NULL
in	NULL
immunoprecipitation	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
of	NULL
MEL	NULL
cells	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
either	NULL
anti-GATA-1	NULL
{	NULL
a-GATA-1	NULL
)	NULL
and	NULL
anti-p16	NULL
{	NULL
a	NULL
«	NULL
-control	NULL
)	NULL
antibodies	NULL
or	NULL
anti-PU.1	NULL
{	NULL
a-PU.1	NULL
)	NULL
and	NULL
anti-cyclin	NULL
E	NULL
{	NULL
«	NULL
-control	NULL
)	NULL
antibodies	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Input	NULL
lanes	NULL
are	NULL
shown	NULL
as	NULL
in	NULL
A	NULL
,	NULL
except	NULL
that	NULL
3	NULL
%	NULL
of	NULL
the	NULL
extract	NULL
was	NULL
analyzed	NULL
for	NULL
the	NULL
immunoprecipitation	NULL
of	NULL
PU.1	NULL
and	NULL
Western	NULL
of	NULL
PU.1	NULL
lane	NULL
.	NULL

Analysis	NULL
of	NULL
immunoprecipitates	NULL
and	NULL
other	NULL
details	NULL
were	NULL
as	NULL
in	NULL
A	NULL
.	NULL

{	NULL
C	NULL
,	NULL
D	NULL
)	NULL
Analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
mutations	NULL
in	NULL
GATA-1	NULL
{	NULL
C	NULL
)	NULL
and	NULL
PU.1	NULL
{	NULL
D	NULL
)	NULL
on	NULL
the	NULL
GATA-I-PU.1	NULL
interaction	NULL
in	NULL
vivo	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
from	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
GATA-1	NULL
and	NULL
PU.1	NULL
proteins	NULL
{	NULL
see	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
D	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
and	NULL
analyzed	NULL
as	NULL
in	NULL
A	NULL
.	NULL

Input	NULL
lanes	NULL
are	NULL
shown	NULL
as	NULL
in	NULL
A.	NULL
bound	NULL
well	NULL
to	NULL
GST-PU.1	NULL
,	NULL
with	NULL
in	NULL
vitro	NULL
affinities	NULL
approxi-	NULL
activation	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
we	NULL
performed	NULL
cotrans-mately	NULL
the	NULL
same	NULL
as	NULL
that	NULL
of	NULL
GATA-1	NULL
[	NULL
Fig	NULL
.	NULL

3E	NULL
)	NULL
.	NULL

fection	NULL
assays	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
and	NULL
Hela	NULL
cells	NULL
with	NULL
PU.1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
three	NULL
different	NULL
reporter	NULL
constructs	NULL
containing	NULL
either	NULL
syn-	NULL
factors	NULL
.	NULL

The	NULL
most	NULL
closely	NULL
related	NULL
Ets	NULL
protein	NULL
is	NULL
Spi-B	NULL
,	NULL
a	NULL
B	NULL
thetic	NULL
(	NULL
Mla	NULL
,	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
B	NULL
and	NULL
«	NULL
D3	NULL
;	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
or	NULL
natural	NULL
(	NULL
p45	NULL
cell-specific	NULL
factor	NULL
.	NULL

Spi-B	NULL
is	NULL
most	NULL
similar	NULL
to	NULL
PU.1	NULL
in	NULL
the	NULL
NF-E2	NULL
;	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
GATA-1-dependent	NULL
promoters	NULL
.	NULL

The	NULL
p45	NULL
Ets	NULL
domain	NULL
;	NULL
the	NULL
two	NULL
proteins	NULL
are	NULL
much	NULL
less	NULL
similar	NULL
in	NULL
NF-EZ2	NULL
promoter	NULL
requires	NULL
the	NULL
synergistic	NULL
action	NULL
of	NULL
other	NULL
regions	NULL
(	NULL
Ray	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
)	NULL
.	NULL

Fli-1	NULL
is	NULL
related	NULL
more	NULL
dis-	NULL
GATA-1	NULL
and	NULL
FOG	NULL
as	NULL
a	NULL
cofactor	NULL
(	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Co-tantly	NULL
to	NULL
PU.1	NULL
,	NULL
but	NULL
like	NULL
PU.1	NULL
it	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
expression	NULL
of	NULL
PU.1	NULL
along	NULL
with	NULL
GATA-1	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
mouse	NULL
erythroleukemia	NULL
(	NULL
Ben-David	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
)	NULL
.	NULL

Both	NULL
Ets	NULL
reduction	NULL
in	NULL
GATA-l-mediated	NULL
transactivation	NULL
of	NULL
all	NULL
proteins	NULL
bound	NULL
to	NULL
GST-GATA-1	NULL
,	NULL
although	NULL
the	NULL
interac-	NULL
three	NULL
reporters	NULL
.	NULL

Inhibition	NULL
by	NULL
PU.1	NULL
was	NULL
dose	NULL
dependent	NULL
.	NULL

tion	NULL
was	NULL
much	NULL
weaker	NULL
than	NULL
with	NULL
PU.1	NULL
(	NULL
Fig	NULL
.	NULL

3F	NULL
)	NULL
.	NULL

The	NULL
With	NULL
the	NULL
natural	NULL
p45	NULL
NF-EZ2	NULL
promoter	NULL
,	NULL
the	NULL
largest	NULL
weak	NULL
interaction	NULL
of	NULL
Spi-B	NULL
with	NULL
GATA-1	NULL
points	NULL
to	NULL
a	NULL
high	NULL
amount	NULL
of	NULL
PU.1	NULL
expression	NULL
plasmid	NULL
used	NULL
led	NULL
to	NULL
a	NULL
reduc-degree	NULL
of	NULL
specificity	NULL
in	NULL
the	NULL
interaction	NULL
between	NULL
PU.1	NULL
and	NULL
tion	NULL
in	NULL
the	NULL
stimulation	NULL
by	NULL
GATA-1	NULL
plus	NULL
FOG	NULL
to	NULL
the	NULL
GATA-1	NULL
.	NULL

The	NULL
observed	NULL
interactions	NULL
of	NULL
GATA	NULL
and	NULL
Ets	NULL
basal	NULL
activitiy	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
}	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
family	NULL
members	NULL
with	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
,	NULL
respectively	NULL
,	NULL
PU.1	NULL
is	NULL
specific	NULL
for	NULL
GATA-1-mediated	NULL
transactivation	NULL
as	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
mapping	NULL
of	NULL
the	NULL
interaction	NULL
sites	NULL
coexpression	NULL
of	NULL
PU.1	NULL
did	NULL
not	NULL
affect	NULL
another	NULL
reporter	NULL
that	NULL
on	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
to	NULL
their	NULL
respective	NULL
DNA-binding	NULL
is	NULL
activated	NULL
by	NULL
a	NULL
GAL4-Spl	NULL
fusion	NULL
protein	NULL
{	NULL
Fig	NULL
.	NULL

4E	NULL
)	NULL
;	NULL
PU.1	NULL
regions	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
such	NULL
interactions	NULL
remains	NULL
to	NULL
also	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
each	NULL
reporter	NULL
.	NULL

be	NULL
determined	NULL
(	NULL
see	NULL
Discussion	NULL
}	NULL
.	NULL

Furthermore	NULL
,	NULL
inhibition	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
cotransfections	NULL
with	NULL
the	NULL
PU.l1	NULL
cDNA	NULL
in	NULL
the	NULL
antisense	NULL
configuration	NULL
(	NULL
PU.1-AS	NULL
;	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Immunoblotting	NULL
of	NULL
extracts	NULL
from	NULL
PU.1	NULL
inhibits	NULL
GATA-1-dependent	NULL
transcriptional	NULL
transfected	NULL
cells	NULL
showed	NULL
that	NULL
coexpression	NULL
of	NULL
PU.1	NULL
did	NULL
activity	NULL
not	NULL
reduce	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
protein	NULL
produced	NULL
in	NULL
the	NULL
On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
well-established	NULL
function	NULL
of	NULL
GATA-1	NULL
transfected	NULL
cells	NULL
[	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
C	NULL
insets	NULL
)	NULL
.	NULL

Coexpression	NULL
of	NULL
the	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
promotes	NULL
expression	NULL
of	NULL
carboxy-terminally	NULL
deleted	NULL
PU.1	NULL
protein	NULL
that	NULL
does	NULL
not	NULL
many	NULL
erythroid-expressed	NULL
genes	NULL
{	NULL
Shivdasani	NULL
and	NULL
Orkin	NULL
interact	NULL
with	NULL
GATA-1	NULL
failed	NULL
to	NULL
inhibit	NULL
GATA-l-medi-1996	NULL
)	NULL
,	NULL
and	NULL
our	NULL
earlier	NULL
finding	NULL
that	NULL
PU.1	NULL
can	NULL
inhibit	NULL
MEL	NULL
ated	NULL
transactivation	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
PU.1	NULL
PEST	NULL
region	NULL
,	NULL
cell	NULL
erythroid	NULL
differentiation	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
,	NULL
the	NULL
obser-	NULL
which	NULL
does	NULL
not	NULL
affect	NULL
interaction	NULL
with	NULL
GATA-1	NULL
,	NULL
also	NULL
vation	NULL
that	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
interact	NULL
could	NULL
suggest	NULL
that	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
PU.1	NULL
to	NULL
repress	NULL
GATA-1-PU.1	NULL
is	NULL
able	NULL
to	NULL
inhibit	NULL
GATA-1-mediated	NULL
transcriptional	NULL
mediated	NULL
transactivation	NULL
.	NULL

Interestingly	NULL
,	NULL
deletion	NULL
of	NULL
a	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1401	NULL
Rekhtman	NULL
et	NULL
al	NULL
.	NULL

A	NULL
PU.1	NULL
B	NULL
ﬁ	NULL
.	NULL

4	NULL
;	NULL
Zn~ﬁn	NULL
Ets	NULL
va	NULL
g	NULL
408	NULL
3	NULL
GATAMI	NULL
Aﬁngiis	NULL
AN	NULL
‘	NULL
M	NULL
AC	NULL
“	NULL
dlSIC~	NULL
10	NULL
%	NULL
Input	NULL
Cling	NULL
?	NULL

_	NULL
\	NULL
31—15	NULL
?	NULL

ans	NULL
2	NULL
3	NULL
&	NULL
B	NULL
z	NULL
y	NULL
&	NULL
3	NULL
3	NULL
3	NULL
3	NULL
So	NULL
vor	NULL
3	NULL
3	NULL
-	NULL
GaTa-1	NULL
9	NULL
Q	NULL
g	NULL
f	NULL
Td	NULL
a	NULL
{	NULL
&	NULL
&	NULL
&	NULL
a	NULL
ee	NULL
t	NULL
&	NULL
5	NULL
_	NULL
aAfingers	NULL
Al-5	NULL
5	NULL
§	NULL
oR	NULL
&	NULL
&	NULL
&	NULL
$	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
445k	NULL
,	NULL
%	NULL
&	NULL
&	NULL
&	NULL
;	NULL
HZ	NULL
33	NULL
8	NULL
38	NULL
§	NULL
&	NULL
S	NULL
&	NULL
:	NULL
s	NULL
S	NULL
$	NULL
S8	NULL
S8	NULL
S	NULL
S	NULL
S	NULL
8	NULL
S	NULL
S	NULL
S	NULL
$	NULL
9	NULL
44	NULL
%	NULL
4	NULL
S	NULL
$	NULL
S	NULL
f	NULL
fingers	NULL
=	NULL
oY	NULL
YoY	NULL
¥	NULL
0	NULL
90	NULL
Y	NULL
9	NULL
Fo	NULL
Y	NULL
YoY	NULL
Y	NULL
Y	NULL
o	NULL
Y	NULL
Y	NULL
Y	NULL
%	NULL
POG	NULL
P	NULL
40	NULL
%	NULL
7	NULL
200	NULL
-	NULL
248	NULL
AN	NULL
ltte	NULL
_	NULL
_	NULL
ho	NULL
AC	NULL
249	NULL
290	NULL
-	NULL
--	NULL
-g	NULL
-	NULL
=	NULL
--	NULL
kaw	NULL
=	NULL
=-C	NULL
orr	NULL
omer	NULL
-3	NULL
i	NULL
C	NULL
finger	NULL
229	NULL
333	NULL
C	NULL
PU.1	NULL
APEST	NULL
_ADBD	NULL
_ATAD	NULL
ANP	NULL
ANS	NULL
D	NULL
:	NULL
:	NULL
p	NULL
p	NULL
7	NULL
p	NULL
5	NULL
a	NULL
E	NULL
&	NULL
E	NULL
E	NULL
10	NULL
%	NULL
Input	NULL
___	NULL
-TAD-PEST-DBD-L	NULL
?	NULL

L	NULL
?	NULL

C	NULL
“	NULL
.-	NULL
Q	NULL
t	NULL
?	NULL

(	NULL
I	NULL
:	NULL
E	NULL
;	NULL
-	NULL
2a	NULL
n	NULL
PUlcllzzl	NULL
:	NULL
[	NULL
_2T	NULL
%	NULL
hoR	NULL
E	NULL
Bo	NULL
R	NULL
BR	NULL
Eb	NULL
BoR	NULL
h	NULL
B	NULL
B	NULL
2	NULL
a	NULL
@	NULL
<	NULL
&	NULL
z	NULL
118	NULL
_	NULL
160	NULL
=	NULL
4	NULL
%	NULL
a	NULL
%	NULL
a	NULL
%	NULL
92	NULL
m	NULL
~	NULL
a	NULL
a	NULL
3	NULL
&	NULL
A	NULL
o	NULL
$	NULL
$	NULL
$	NULL
$	NULL
$	NULL
8	NULL
$	NULL
$	NULL
$	NULL
$	NULL
$	NULL
$	NULL
2	NULL
3	NULL
2	NULL
4	NULL
1	NULL
:	NULL
APRN	NULL
CO	NULL
ap	NULL
C	NULL
ADBD	NULL
ao	NULL
--	NULL
--	NULL
-r	NULL
--	NULL
nifg	NULL
mae	NULL
QTADn-E	NULL
?	NULL

8.021-_	NULL
cames	NULL
faw	NULL
ﬂNPDéIS	NULL
F	NULL
‘	NULL
s	NULL
:	NULL
-C	NULL
s=	NULL
``	NULL
°C	NULL
withs	NULL
mt	NULL
cam	NULL
--	NULL
ANS	NULL
aB	NULL
E-	NULL
rmmmr	NULL
E	NULL
PU.1	NULL
Fli-1	NULL
Spi-B	NULL
GATA_—_1	NULL
GATA-E	NULL
GATA-3	NULL
20	NULL
%	NULL
Input	NULL
ﬁ	NULL
[	NULL
<	NULL
5	NULL
ﬁ	NULL
5	NULL
5	NULL
a	NULL
n	NULL
<	NULL
<	NULL
<	NULL
10	NULL
%	NULL
Input	NULL
2	NULL
_	NULL
2	NULL
_	NULL
R	NULL
i	NULL
1	NULL
f	NULL
$	NULL
_	NULL
$	NULL
0	NULL
_	NULL
$	NULL
<	NULL
``	NULL
L-5	NULL
5	NULL
3	NULL
5	NULL
5	NULL
&	NULL
4	NULL
4	NULL
&	NULL
&	NULL
§	NULL
&	NULL
&	NULL
§	NULL
§	NULL
5	NULL
Z	NULL
@	NULL
o	NULL
G	NULL
5	NULL
G6	NULL
G	NULL
G6	NULL
S0	NULL
G	NULL
o	NULL
5	NULL
0	NULL
0	NULL
6	NULL
5	NULL
0	NULL
K	NULL
E	NULL
a	NULL
+	NULL
1	NULL
+	NULL
1	NULL
1	NULL
1	NULL
1	NULL
U	NULL
U	NULL
U	NULL
U	NULL
U	NULL
U	NULL
U	NULL
U	NULL
1	NULL
a	NULL
1	NULL
wate	NULL
we	NULL
.-	NULL
``	NULL
He	NULL
wam	NULL
Suite	NULL
wam	NULL
«	NULL
wigs	NULL
Figure	NULL
3	NULL
.	NULL

The	NULL
PU.1-GATA-1	NULL
interaction	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
of	NULL
GATA-1	NULL
and	NULL
the	NULL
Ets	NULL
region	NULL
of	NULL
PU.1	NULL
.	NULL

Binding	NULL
of	NULL
PU.1	NULL
to	NULL
wild-type	NULL
and	NULL
mutant	NULL
GST-GATA-1	NULL
fusion	NULL
proteins	NULL
{	NULL
A	NULL
,	NULL
left	NULL
}	NULL
,	NULL
or	NULL
*°S-labeled	NULL
wild-type	NULL
and	NULL
mutant	NULL
GATA-1	NULL
proteins	NULL
to	NULL
GST-PU.1	NULL
{	NULL
A	NULL
,	NULL
middle	NULL
and	NULL
far	NULL
right	NULL
}	NULL
,	NULL
or	NULL
*S-labeled	NULL
wild-type	NULL
and	NULL
mutant	NULL
PU.1	NULL
proteins	NULL
to	NULL
GST-GATA-1	NULL
{	NULL
C	NULL
)	NULL
was	NULL
tested	NULL
as	NULL
described	NULL
in	NULL
Fig.1	NULL
.	NULL

GST-GUK	NULL
is	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
of	NULL
the	NULL
human	NULL
LINZA	NULL
guanylate	NULL
kinase	NULL
.	NULL

{	NULL
B	NULL
,	NULL
D	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
used	NULL
for	NULL
the	NULL
binding	NULL
studies	NULL
in	NULL
A	NULL
and	NULL
C	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
amino	NULL
acid	NULL
residues	NULL
at	NULL
the	NULL
termini	NULL
of	NULL
regions	NULL
present	NULL
in	NULL
the	NULL
mutant	NULL
proteins	NULL
are	NULL
shown	NULL
above	NULL
the	NULL
diagrams	NULL
.	NULL

[	NULL
TAD	NULL
]	NULL
transactivation	NULL
domain	NULL
;	NULL
{	NULL
PEST	NULL
)	NULL
region	NULL
rich	NULL
in	NULL
PEST	NULL
residues	NULL
;	NULL
{	NULL
DBD	NULL
)	NULL
DNA-binding	NULL
domain	NULL
.	NULL

Binding	NULL
of	NULL
**S-labeled	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
and	NULL
GATA-3	NULL
to	NULL
GST	NULL
or	NULL
GST-PU.1	NULL
{	NULL
E	NULL
)	NULL
or	NULL
*°S-labeled	NULL
PU.1	NULL
,	NULL
Fli-1	NULL
,	NULL
and	NULL
Spi-B	NULL
to	NULL
GST	NULL
or	NULL
GST-GATA-1	NULL
{	NULL
F	NULL
)	NULL
was	NULL
tested	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1.	NULL
portion	NULL
of	NULL
the	NULL
PU.1	NULL
amino-terminal	NULL
transactivation	NULL
domain	NULL
resulted	NULL
in	NULL
a	NULL
loss	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
repress	NULL
GATA-1-mediated	NULL
transactivation	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
con-sistent	NULL
,	NULL
approximately	NULL
twofold	NULL
stimulation	NULL
of	NULL
GATA-1-mediated	NULL
transactivation	NULL
when	NULL
this	NULL
PU.1	NULL
mutant	NULL
was	NULL
coexpressed	NULL
with	NULL
GATA-1	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
PU.1	NULL
proteins	NULL
were	NULL
produced	NULL
at	NULL
levels	NULL
comparable	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
full-length	NULL
PU.1	NULL
as	NULL
determined	NULL
by	NULL
anti-HA	NULL
immunoblotting	NULL
of	NULL
HA-tagged	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
inset	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
like	NULL
wild-type	NULL
PU.1	NULL
,	NULL
the	NULL
three	NULL
types	NULL
of	NULL
mutant	NULL
PU.1	NULL
molecules	NULL
are	NULL
able	NULL
to	NULL
localize	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
immunoblotting	NULL
of	NULL
nuclear	NULL
and	NULL
cyto-plasmic	NULL
extracts	NULL
of	NULL
transfected	NULL
cells	NULL
(	NULL
{	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
repression	NULL
of	NULL
GATA-1	NULL
by	NULL
PU.1	NULL
requires	NULL
both	NULL
the	NULL
carboxy-terminal	NULL
DNA-binding	NULL
region	NULL
and	NULL
the	NULL
amino-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
PU.1	NULL
.	NULL

Both	NULL
the	NULL
DNA-binding	NULL
and	NULL
transactivation	NULL
domains	NULL
of	NULL
PU.1	NULL
are	NULL
required	NULL
for	NULL
blocking	NULL
erythroid	NULL
differentiation	NULL
Treatment	NULL
of	NULL
MEL	NULL
cells	NULL
with	NULL
several	NULL
chemical	NULL
agents	NULL
1402	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
that	NULL
cause	NULL
the	NULL
cells	NULL
to	NULL
reinitiate	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
leads	NULL
to	NULL
a	NULL
very	NULL
rapid	NULL
decline	NULL
in	NULL
PU.1	NULL
levels	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
transfection	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
an	NULL
expression	NULL
construct	NULL
that	NULL
constitutively	NULL
produces	NULL
PU.1	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
differentiation	NULL
inducers	NULL
,	NULL
causes	NULL
a	NULL
block	NULL
to	NULL
differentiation	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Having	NULL
determined	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
requires	NULL
an	NULL
intact	NULL
PU.1	NULL
DNA-binding	NULL
domain	NULL
,	NULL
and	NULL
that	NULL
repression	NULL
of	NULL
GATA-1	NULL
requires	NULL
both	NULL
that	NULL
domain	NULL
and	NULL
the	NULL
transactivation	NULL
domain	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
regions	NULL
of	NULL
PU.1	NULL
are	NULL
also	NULL
needed	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
block	NULL
MEL	NULL
cell	NULL
differentiation	NULL
.	NULL

We	NULL
prepared	NULL
stable	NULL
MEL	NULL
cell	NULL
transfectants	NULL
expressing	NULL
either	NULL
an	NULL
epitope-tagged	NULL
(	NULL
HA	NULL
)	NULL
PU.1	NULL
protein	NULL
or	NULL
tagged	NULL
,	NULL
mutant	NULL
PU.1	NULL
proteins	NULL
containing	NULL
deletions	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
or	NULL
the	NULL
transactivation	NULL
domain	NULL
.	NULL

Stable	NULL
MEL	NULL
cell	NULL
transfectants	NULL
expressing	NULL
wild-type	NULL
and	NULL
mutant	NULL
proteins	NULL
were	NULL
identified	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
anti-HA	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Transfectants	NULL
expressing	NULL
amounts	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
similar	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
wild-type	NULL
PU.1	NULL
were	NULL
then	NULL
tested	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
undergo	NULL
differentiation	NULL
and	NULL
form	NULL
benzidine-positive	NULL
,	NULL
hemoglo-	NULL
Interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
M1c-GH	NULL
B	NULL
_.	NULL
M1c-GH	NULL
45	NULL
.	NULL

___	NULL
CGATA-1	NULL
aan	NULL
aaa	NULL
aat	NULL
-	NULL
Mi6	NULL
~	NULL
a	NULL
005	NULL
|	NULL
6	NULL
190.6	NULL
7	NULL
175.7	NULL
165.7	NULL
Fold	NULL
Activation	NULL
g	NULL
g	NULL
24.8	NULL
a	NULL
€	NULL
o	NULL
in	NULL
£	NULL
to	NULL
#	NULL
99	NULL
$	NULL
+	NULL
-e	NULL
;	NULL
.	NULL

*	NULL
LTT	NULL
G	NULL
TGT	NULL
4C	NULL
s	NULL
[	NULL
«	NULL
T	NULL
|	NULL
T	NULL
150ng	NULL
GATA-1	NULL
*	NULL
|	NULL
+	NULL
]	NULL
+1	NULL
]	NULL
+	NULL
|	NULL
+	NULL
|	NULL
+	NULL
PU	NULL
.	NULL

1	NULL
]	NULL
___|	NULL
180	NULL
|	NULL
180	NULL
90	NULL
|	NULL
4	NULL
_	NULL
``	NULL
h	NULL
--	NULL
AS	NULL
|	NULL
|	NULL
PU.1-AS	NULL
}	NULL
PU	NULL
.	NULL

1-AS	NULL
[	NULL
__|	NULL
180	NULL
180	NULL
90	NULL
|	NULL
30	NULL
eu	NULL
abed	NULL
-/	NULL
-|	NULL
&	NULL
g	NULL
)	NULL
0	NULL
PU.1-ATAD	NULL
|	NULL
I	NULL
--	NULL
_	NULL
1180	NULL
;	NULL
_|	NULL
PU.1-APEST	NULL
180	NULL
]	NULL
sao	NULL
cD3-LUC	NULL
D	NULL
p45-GH	NULL
E	NULL
1	NULL
14	NULL
r	NULL
--	NULL
-__	NULL
20r	NULL
--	NULL
--	NULL
uss	NULL
|	NULL
mas	NULL
12,30	NULL
17	NULL
|	NULL
sao	NULL
cGaTa-1	NULL
@	NULL
@	NULL
an	NULL
om	NULL
em-	NULL
*	NULL
a	NULL
r	NULL
s	NULL
8	NULL
s	NULL
10	NULL
ut	NULL
.	NULL

ts	NULL
§	NULL
ao	NULL
§	NULL
``	NULL
}	NULL
&	NULL
B	NULL
E	NULL
I	NULL
g	NULL
12	NULL
2	NULL
300	NULL
é	NULL
<	NULL
‘	NULL
3	NULL
|	NULL
3	NULL
3	NULL
:	NULL
[	NULL
2	NULL
KID	NULL
;	NULL
169.7	NULL
158.9	NULL
1982	NULL
LL	NULL
:	NULL
2	NULL
8	NULL
|	NULL
_	NULL
107.1	NULL
$	NULL
1.0	NULL
2.	NULL
tan	NULL
|	NULL
85.0	NULL
,	NULL
§	NULL
;	NULL
|	NULL
a	NULL
1	NULL
os	NULL
09	NULL
i2	NULL
is	NULL
10	NULL
i	NULL
j	NULL
a	NULL
-	NULL
in	NULL
0	NULL
-y	NULL
-	NULL
-z	NULL
-__	NULL
___	NULL
.	NULL

1	NULL
a	NULL
a	NULL
112	NULL
|	NULL
3	NULL
|	NULL
&	NULL
[	NULL
s	NULL
|e	NULL
|	NULL
7	NULL
|	NULL
s	NULL
|	NULL
s	NULL
|	NULL
a/	NULL
nl	NULL
ar	NULL
}	NULL
is	NULL
}	NULL
is	NULL
]	NULL
100ng	NULL
GATA-	NULL
+	NULL
|	NULL
+	NULL
.	NULL

I	NULL
4	NULL
+	NULL
30ng	NULL
GATA-1	NULL
[	NULL
+	NULL
]	NULL
+	NULL
|	NULL
#	NULL
£1¥	NULL
]	NULL
+	NULL
]	NULL
+	NULL
[	NULL
+	NULL
15mg	NULL
FOG	NULL
+	NULL
|_	NULL
+1	NULL
100ne	NULL
“	NULL
up	NULL
?	NULL

11	NULL
|	NULL
180	NULL
iso	NULL
|	NULL
PU.1	NULL
|__1150/100	NULL
]	NULL
50	NULL
|__	NULL
|1s0|to0	NULL
``	NULL
50	NULL
Pu	NULL
.	NULL
'	NULL

AOCS	NULL
PU.1-ADBD	NULL
150	NULL
(	NULL
(	NULL
50	NULL
)	NULL
©	NULL
<	NULL
=	NULL
~	NULL
PU.1-ATAD	NULL
150	NULL
|	NULL
150	NULL
PU.1-APEST	NULL
(	NULL
150	NULL
150	NULL
Figure	NULL
4	NULL
.	NULL

PU	NULL
.	NULL
]	NULL

inhibits	NULL
GATA-l-dependent	NULL
transcriptional	NULL
activity	NULL
with	NULL
synthetic	NULL
and	NULL
natural	NULL
promoters	NULL
.	NULL

Mla-GH	NULL
reporter	NULL
{	NULL
15	NULL
ng	NULL
]	NULL
with	NULL
and	NULL
without	NULL
either	NULL
150	NULL
ng	NULL
{	NULL
A	NULL
]	NULL
or	NULL
60	NULL
ng	NULL
{	NULL
B	NULL
)	NULL
of	NULL
pXM-GATA-1	NULL
were	NULL
cotransfected	NULL
with	NULL
pEBB	NULL
or	NULL
the	NULL
indicated	NULL
amounts	NULL
{	NULL
nanograms	NULL
}	NULL
of	NULL
pEBB	NULL
expression	NULL
constructs	NULL
encoding	NULL
PU.1	NULL
,	NULL
reverse	NULL
transcripts	NULL
of	NULL
PU.1	NULL
{	NULL
(	NULL
AS-PU.1	NULL
}	NULL
,	NULL
or	NULL
the	NULL
indicated	NULL
PU.1	NULL
mutants	NULL
{	NULL
see	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
into	NULL
NIH	NULL
3T3-cells	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

{	NULL
C	NULL
)	NULL
«	NULL
D3-LUC	NULL
reporter	NULL
{	NULL
15	NULL
ng	NULL
]	NULL
with	NULL
and	NULL
without	NULL
30	NULL
ng	NULL
of	NULL
pXM-GATA-1	NULL
were	NULL
cotransfected	NULL
with	NULL
pEBB	NULL
or	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
plasmids	NULL
as	NULL
in	NULL
B	NULL
into	NULL
Hela	NULL
cells	NULL
.	NULL

{	NULL
D	NULL
]	NULL
p45	NULL
NF-EZ-GH	NULL
reporter	NULL
{	NULL
10	NULL
ng	NULL
)	NULL
with	NULL
and	NULL
without	NULL
100	NULL
ng	NULL
of	NULL
pXM-GATA-1	NULL
and	NULL
100	NULL
ng	NULL
pMT2-FOG	NULL
were	NULL
cotransfected	NULL
with	NULL
pEBB	NULL
or	NULL
the	NULL
indicated	NULL
amounts	NULL
pEBB-PU.1	NULL
into	NULL
NIH-3T3	NULL
cells	NULL
as	NULL
in	NULL
A	NULL
.	NULL

{	NULL
E	NULL
)	NULL
UAS-LUC	NULL
reporter	NULL
{	NULL
100	NULL
ng	NULL
]	NULL
were	NULL
cotransfected	NULL
into	NULL
NIH-3T3	NULL
with	NULL
and	NULL
without	NULL
100	NULL
ng	NULL
of	NULL
SP6-GAL4-Spl	NULL
and	NULL
180	NULL
ng	NULL
of	NULL
pEBB-PU.1	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
growth	NULL
hormone	NULL
{	NULL
A,8	NULL
,	NULL
D	NULL
}	NULL
or	NULL
luciferase	NULL
activity	NULL
{	NULL
C	NULL
,	NULL
E	NULL
]	NULL
were	NULL
determined	NULL
48	NULL
hr	NULL
after	NULL
transfection	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

{	NULL
Insets	NULL
in	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C	NULL
)	NULL
The	NULL
immunoblots	NULL
with	NULL
anti-GATA-1	NULL
antibody	NULL
(	NULL
A	NULL
,	NULL
C	NULL
)	NULL
and	NULL
anti-HA	NULL
antibody	NULL
(	NULL
B	NULL
)	NULL
of	NULL
cell	NULL
extracts	NULL
corresponding	NULL
to	NULL
the	NULL
indicated	NULL
transfected	NULL
samples	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
GATA-1	NULL
and	NULL
HA-tagged	NULL
full-length	NULL
and	NULL
mutant	NULL
PU.1	NULL
proteins	NULL
;	NULL
the	NULL
asterisked	NULL
{	NULL
*	NULL
]	NULL
arrowhead	NULL
indicates	NULL
a	NULL
nonspecific	NULL
band	NULL
detected	NULL
with	NULL
anti-HA	NULL
antibody	NULL
in	NULL
293	NULL
extracts	NULL
.	NULL

Numbers	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
transfections	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
the	NULL
s.E.m..	NULL
Each	NULL
type	NULL
of	NULL
experiment	NULL
was	NULL
performed	NULL
between	NULL
three	NULL
and	NULL
seven	NULL
times	NULL
with	NULL
two	NULL
or	NULL
three	NULL
different	NULL
DNA	NULL
preparations	NULL
and	NULL
produced	NULL
similar	NULL
results	NULL
.	NULL

binized	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
hexamethylene	NULL
bisacetamide	NULL
tagged	NULL
PU.1	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
;	NULL
these	NULL
control	NULL
trans-	NULL
(	NULL
HMBA	NULL
)	NULL
,	NULL
an	NULL
inducer	NULL
of	NULL
differentiation	NULL
.	NULL

Transfectants	NULL
fectants	NULL
differentiated	NULL
well	NULL
.	NULL

Transfectants	NULL
expressing	NULL
that	NULL
did	NULL
not	NULL
express	NULL
any	NULL
detectable	NULL
wild-type	NULL
or	NULL
mutant-	NULL
wild-type	NULL
PU.1	NULL
were	NULL
blocked	NULL
completely	NULL
for	NULL
differentia-	NULL
tion	NULL
,	NULL
whereas	NULL
clones	NULL
expressing	NULL
the	NULL
mutant	NULL
proteins	NULL
were	NULL
fully	NULL
capable	NULL
of	NULL
differentiating	NULL
(	NULL
Table	NULL
1	NULL
}	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
PEST	NULL
region	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
aap	NULL
__	NULL
ability	NULL
of	NULL
PU.1	NULL
to	NULL
block	NULL
MEL	NULL
cell	NULL
differentiation	NULL
(	NULL
F.	NULL
Rad-	NULL
.	NULL

w-	NULL
/a	NULL
wae	NULL
sae	NULL
..	NULL
parvar	NULL
and	NULL
AI	NULL
.	NULL

Skoultchi	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

These	NULL
results	NULL
indi-	NULL
``	NULL
w	NULL
cate	NULL
that	NULL
both	NULL
regions	NULL
of	NULL
PU.1	NULL
required	NULL
for	NULL
repressing	NULL
GATA-l-mediated	NULL
transcription	NULL
are	NULL
also	NULL
necessary	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
PU.1	NULL
in	NULL
blocking	NULL
differentiation	NULL
.	NULL

,	NULL
PU	NULL
.	NULL

1-HA	NULL
,	NULL
rPU.1-¢\DBD	NULL
»	NULL
HA	NULL
PU.1-ATAD-HA	NULL
MEL	NULL
Clone	NULL
_	NULL
51	NULL
64	NULL
49	NULL
51	NULL
40	NULL
41	NULL
Figure	NULL
5	NULL
.	NULL

Detection	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
epitope-tagged	NULL
PU.1	NULL
proteins	NULL
in	NULL
MEL	NULL
cell	NULL
transfectants	NULL
.	NULL

MEL	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
constructs	NULL
encoding	NULL
both	NULL
resistance	NULL
to	NULL
puromycin	NULL
and	NULL
an	NULL
influenza	NULL
hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
-epitope	NULL
tagged	NULL
wild-type	NULL
or	NULL
mutant	NULL
PU.1	NULL
proteins	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
GATA-1	NULL
relieves	NULL
a	NULL
block	NULL
to	NULL
erythroid	NULL
differentiation	NULL
Methods	NULL
.	NULL

Puromycin	NULL
resistant	NULL
clones	NULL
were	NULL
isolated	NULL
and	NULL
imposed	NULL
by	NULL
PU.1	NULL
screened	NULL
for	NULL
expression	NULL
of	NULL
PU.1	NULL
proteins	NULL
by	NULL
immunoblotting	NULL
of	NULL
cell	NULL
extracts	NULL
with	NULL
anti-HA	NULL
antibody	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
PU.1	NULL
proteins	NULL
{	NULL
arrowhead	NULL
)	NULL
in	NULL
two	NULL
representative	NULL
clones	NULL
of	NULL
each	NULL
type	NULL
of	NULL
PU.1	NULL
As	NULL
mentioned	NULL
above	NULL
,	NULL
during	NULL
chemically	NULL
induced	NULL
reini-tiation	NULL
of	NULL
MEL	NULL
cell	NULL
differentiation	NULL
PU.1	NULL
levels	NULL
decline	NULL
transfectant	NULL
are	NULL
shown	NULL
.	NULL

PU.1-ADBD-HA	NULL
is	NULL
deleted	NULL
for	NULL
residues	NULL
rapidly	NULL
.	NULL

W	NULL
?	NULL

described	NULL
previously	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
and	NULL
in	NULL
201-272	NULL
and	NULL
PU.1-ATAD-HA	NULL
is	NULL
deleted	NULL
for	NULL
residues	NULL
33-100	NULL
the	NULL
preceding	NULL
section	NULL
,	NULL
MEL	NULL
cell	NULL
transfectants	NULL
that	NULL
ex-	NULL
{	NULL
see	NULL
Fig	NULL
.	NULL

3D	NULL
}	NULL
.	NULL

press	NULL
PU.1	NULL
constitutively	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
differ	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1403	NULL
Rekhtman	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
1	NULL
.	NULL

Response	NULL
of	NULL
MEL	NULL
cell	NULL
transfectants	NULL
to	NULL
HMBA	NULL
treatment	NULL
Percent	NULL
benzidine-positive	NULL
cells	NULL
``	NULL
Clone*	NULL
day	NULL
3	NULL
day	NULL
5	NULL
PU.1-HA	NULL
expressors	NULL
35	NULL
0	NULL
0	NULL
39	NULL
0	NULL
0	NULL
51	NULL
0	NULL
2	NULL
64	NULL
0	NULL
1	NULL
PU.1-HA	NULL
nonexpressors	NULL
12	NULL
74	NULL
100	NULL
15	NULL
74	NULL
93	NULL
PU.1-ADBD-HA	NULL
expressors	NULL
29	NULL
90	NULL
91	NULL
44	NULL
76	NULL
90	NULL
49	NULL
95	NULL
N.D.	NULL
51	NULL
74	NULL
90	NULL
PU.1-ADBD-HA	NULL
nonexpressors	NULL
25	NULL
90	NULL
92	NULL
43	NULL
62	NULL
90	NULL
PU.1-ATAD-HA	NULL
expressors	NULL
37	NULL
91	NULL
N.D.	NULL
40	NULL
93	NULL
100	NULL
41	NULL
92	NULL
100	NULL
50	NULL
81	NULL
N.D.	NULL
PU.1-ATAD-HA	NULL
nonexpressors	NULL
54	NULL
100	NULL
N.D.	NULL
60	NULL
95	NULL
N.D.	NULL
MEL	NULL
84	NULL
93	NULL
{	NULL
N.D.	NULL
)	NULL
Not	NULL
determined	NULL
.	NULL

``	NULL
Expression	NULL
levels	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
PU.1	NULL
proteins	NULL
in	NULL
representative	NULL
transfectants	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Clones	NULL
indicated	NULL
as	NULL
nonexpressors	NULL
did	NULL
not	NULL
produce	NULL
any	NULL
detectable	NULL
epitope-tagged	NULL
protein	NULL
on	NULL
immunoblots	NULL
like	NULL
that	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
6-10	NULL
additional	NULL
clones	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

``	NULL
Cells	NULL
were	NULL
treated	NULL
with	NULL
5	NULL
mm	NULL
HMBA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
the	NULL
percent	NULL
hemoglobinized	NULL
,	NULL
benzidine-positive	NULL
cells	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

entiation	NULL
inducers	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
blocked	NULL
from	NULL
differentiating	NULL
in	NULL
response	NULL
to	NULL
inducers	NULL
,	NULL
attributable	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
exogenous	NULL
PU.1	NULL
.	NULL

We	NULL
wondered	NULL
whether	NULL
the	NULL
differentiation	NULL
block	NULL
specifically	NULL
imposed	NULL
by	NULL
PU.l1	NULL
in	NULL
these	NULL
transfectants	NULL
could	NULL
be	NULL
relieved	NULL
by	NULL
providing	NULL
the	NULL
cells	NULL
with	NULL
additional	NULL
GATA-1	NULL
.	NULL

We	NULL
transfected	NULL
one	NULL
such	NULL
PU.1-transfectant	NULL
[	NULL
PU.1	NULL
clone	NULL
605	NULL
;	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
a	NULL
second	NULL
time	NULL
with	NULL
a	NULL
construct	NULL
expressing	NULL
a	NULL
conditionally	NULL
active	NULL
form	NULL
of	NULL
GATA-1	NULL
,	NULL
achieved	NULL
by	NULL
fusing	NULL
GATA-1	NULL
coding	NULL
sequences	NULL
to	NULL
the	NULL
ligand-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
estrogen	NULL
receptor	NULL
{	NULL
ER	NULL
)	NULL
.	NULL

The	NULL
GATA-1/ER	NULL
fusion	NULL
protein	NULL
is	NULL
activated	NULL
for	NULL
GATA-1	NULL
dependent	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
estrogen	NULL
{	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Supertransfectants	NULL
of	NULL
the	NULL
clone	NULL
605	NULL
expressing	NULL
the	NULL
GATA-1/ER	NULL
fusion	NULL
protein	NULL
were	NULL
identified	NULL
by	NULL
immunoblotting	NULL
.	NULL

These	NULL
transfectants	NULL
were	NULL
studied	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
various	NULL
treatments	NULL
.	NULL

Like	NULL
the	NULL
parental	NULL
clone	NULL
605	NULL
cells	NULL
,	NULL
the	NULL
supertransfectants	NULL
exhibited	NULL
a	NULL
block	NULL
to	NULL
dif-	NULL
1404	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
ferentiation	NULL
in	NULL
response	NULL
to	NULL
HMBA	NULL
,	NULL
producing	NULL
<	NULL
10	NULL
%	NULL
benzidine-positive	NULL
,	NULL
hemoglobinized	NULL
cells	NULL
when	NULL
cultured	NULL
for	NULL
5	NULL
days	NULL
in	NULL
HMBA	NULL
(	NULL
Fig	NULL
.	NULL

6A-C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
these	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
HMBA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
estrogen	NULL
they	NULL
produced	NULL
large	NULL
numbers	NULL
of	NULL
differentiated	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
combination	NULL
of	NULL
HMBA	NULL
and	NULL
estrogen	NULL
did	NULL
not	NULL
increase	NULL
the	NULL
percentage	NULL
of	NULL
differentiated	NULL
cells	NULL
in	NULL
the	NULL
parental	NULL
clone	NULL
605	NULL
line	NULL
above	NULL
that	NULL
observed	NULL
with	NULL
HMBA	NULL
alone	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
the	NULL
605	NULL
line	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
HMBA	NULL
was	NULL
restored	NULL
by	NULL
GATA-1/ER	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
estrogen	NULL
to	NULL
levels	NULL
comparable	NULL
to	NULL
individual	NULL
clones	NULL
of	NULL
MEL	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
GATA-1	NULL
/ER	NULL
in	NULL
these	NULL
cells	NULL
rendered	NULL
them	NULL
able	NULL
to	NULL
differentiate	NULL
with	NULL
estrogen	NULL
treatment	NULL
alone	NULL
,	NULL
without	NULL
the	NULL
need	NULL
for	NULL
HMBA	NULL
[	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
relief	NULL
of	NULL
the	NULL
block	NULL
to	NULL
differentiation	NULL
in	NULL
the	NULL
erythroleukemia	NULL
cells	NULL
appears	NULL
to	NULL
require	NULL
only	NULL
sufficient	NULL
levels	NULL
of	NULL
active	NULL
GATA-1	NULL
.	NULL

We	NULL
hypothesize	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
HMBA	NULL
and	NULL
estrogen	NULL
may	NULL
induce	NULL
more	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
differentiate	NULL
than	NULL
estrogen	NULL
alone	NULL
because	NULL
HMBA	NULL
may	NULL
cause	NULL
a	NULL
reduction	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
PU.1	NULL
gene	NULL
,	NULL
effectively	NULL
increasing	NULL
the	NULL
amount	NULL
of	NULL
active	NULL
GATA-1	NULL
.	NULL

Whereas	NULL
treatment	NULL
of	NULL
the	NULL
clone	NULL
605	NULL
line	NULL
with	NULL
HMBA	NULL
and	NULL
estrogen	NULL
led	NULL
to	NULL
only	NULL
minimal	NULL
accumulation	NULL
of	NULL
globin	NULL
mRNA	NULL
,	NULL
differentiation	NULL
induced	NULL
in	NULL
the	NULL
GATA-1/ER	NULL
supertransfected	NULL
lines	NULL
by	NULL
HMBA	NULL
plus	NULL
estrogen	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
globin	NULL
mRNA	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
,	NULL
comparable	NULL
to	NULL
that	NULL
induced	NULL
in	NULL
MEL	NULL
cells	NULL
by	NULL
HMBA	NULL
and	NULL
other	NULL
agents	NULL
.	NULL

An	NULL
important	NULL
aspect	NULL
of	NULL
the	NULL
differentiation	NULL
program	NULL
induced	NULL
in	NULL
MEL	NULL
cells	NULL
by	NULL
HMBA	NULL
and	NULL
other	NULL
treatments	NULL
is	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
expression	NULL
of	NULL
many	NULL
erythroid-specific	NULL
markers	NULL
,	NULL
the	NULL
cells	NULL
undergo	NULL
terminal	NULL
cell	NULL
division	NULL
(	NULL
Marks	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

This	NULL
property	NULL
can	NULL
be	NULL
studied	NULL
by	NULL
observing	NULL
the	NULL
proliferation	NULL
of	NULL
individual	NULL
cells	NULL
in	NULL
semisolid	NULL
media	NULL
such	NULL
as	NULL
in	NULL
plasma	NULL
clots	NULL
.	NULL

Cells	NULL
undergoing	NULL
differentiation	NULL
exhibit	NULL
limited	NULL
proliferative	NULL
capacity	NULL
and	NULL
give	NULL
rise	NULL
to	NULL
small	NULL
colonies	NULL
consisting	NULL
of	NULL
a	NULL
maximum	NULL
of	NULL
32-64	NULL
cells	NULL
,	NULL
whereas	NULL
undifferentiated	NULL
cells	NULL
proliferate	NULL
extensively	NULL
and	NULL
produce	NULL
very	NULL
large	NULL
colonies	NULL
consisting	NULL
of	NULL
hundreds	NULL
or	NULL
thousands	NULL
of	NULL
cells	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
PU.1	NULL
blocks	NULL
HMBA-induced	NULL
terminal	NULL
cell	NULL
division	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
,	NULL
allowing	NULL
PU.1	NULL
transfectants	NULL
like	NULL
clone	NULL
605	NULL
to	NULL
form	NULL
large	NULL
colonies	NULL
in	NULL
plasma	NULL
clots	NULL
after	NULL
HMBA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

6E	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
proliferation	NULL
of	NULL
GATA-1/ER	NULL
transfectants	NULL
treated	NULL
with	NULL
HMBA	NULL
,	NULL
estrogen	NULL
,	NULL
or	NULL
both	NULL
agents	NULL
by	NULL
plasma	NULL
clot	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6F	NULL
treatment	NULL
with	NULL
estrogen	NULL
alone	NULL
or	NULL
estrogen	NULL
and	NULL
HMBA	NULL
caused	NULL
the	NULL
cells	NULL
to	NULL
lose	NULL
their	NULL
proliferative	NULL
capacity	NULL
and	NULL
form	NULL
many	NULL
small	NULL
colonies	NULL
,	NULL
whereas	NULL
when	NULL
treated	NULL
with	NULL
HMBA	NULL
alone	NULL
they	NULL
retained	NULL
their	NULL
ability	NULL
to	NULL
divide	NULL
extensively	NULL
and	NULL
produced	NULL
only	NULL
very	NULL
large	NULL
colonies	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
treatment	NULL
of	NULL
the	NULL
605	NULL
parental	NULL
line	NULL
with	NULL
estrogen	NULL
or	NULL
estrogen	NULL
and	NULL
HMBA	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
production	NULL
of	NULL
many	NULL
small	NULL
colonies	NULL
showing	NULL
that	NULL
the	NULL
proliferation	NULL
capacity	NULL
of	NULL
the	NULL
cells	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
estrogen	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
GATA-1	NULL
/ER	NULL
(	NULL
Fig	NULL
.	NULL

6E	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
differentiation	NULL
program	NULL
restored	NULL
in	NULL
the	NULL
PU.l-blocked	NULL
line	NULL
by	NULL
GATA-1/ER	NULL
includes	NULL
terminal	NULL
cell	NULL
division	NULL
.	NULL

The	NULL
foregoing	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
eryth-	NULL
Interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
A	NULL
a	NULL
B	NULL
too	NULL
;	NULL
clone	NULL
605	NULL
1	NULL
too	NULL
clone	NULL
12	NULL
(	NULL
605-GATA-1/ER	NULL
)	NULL
__	NULL
CF	NULL
“	NULL
clone	NULL
13	NULL
(	NULL
605-GATA-1/ER	NULL
)	NULL
_	NULL
a	NULL
807	NULL
/	NULL
897	NULL
45801	NULL
ry	NULL
/	NULL
=	NULL
=	NULL
cu	NULL
,	NULL
/	NULL
§	NULL
3	NULL
4	NULL
80	NULL
/	NULL
60+	NULL
+	NULL
so	NULL
}	NULL
mn	NULL
ll	NULL
MEL-	NULL
»	NULL
,	NULL
E	NULL
:	NULL
:1E	NULL
§	NULL
A	NULL
a	NULL
2	NULL
Em	NULL
[	NULL
d	NULL
|	NULL
§	NULL
‘	NULL
“	NULL
}	NULL
i345	NULL
.	NULL

£	NULL
,	NULL
£	NULL
$	NULL
a	NULL
2	NULL
I	NULL
204	NULL
20	NULL
)	NULL
-/	NULL
/	NULL
l	NULL
-/	NULL
o	NULL
by	NULL
s	NULL
_	NULL
n	NULL
0	NULL
s	NULL
120	NULL
*t	NULL
m	NULL
as	NULL
0	NULL
no	NULL
9s	NULL
o	NULL
m	NULL
4s	NULL
a	NULL
56	NULL
120	NULL
0	NULL
Induction	NULL
Time	NULL
(	NULL
br	NULL
)	NULL
Induction	NULL
Time	NULL
(	NULL
br	NULL
)	NULL
Induction	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
D	NULL
E	NULL
clone	NULL
605	NULL
__	NULL
F	NULL
clone	NULL
13	NULL
(	NULL
605-GATA-1/ER	NULL
)	NULL
__	NULL
Clone	NULL
12	NULL
Clone	NULL
605	NULL
s	NULL
®	NULL
B-estradiol	NULL
``	NULL
-	NULL
+	NULL
+	NULL
-	NULL
+	NULL
A	NULL
HMBA	NULL
-	NULL
~	NULL
+	NULL
_+	NULL
*__*	NULL
é	NULL
aoi	NULL
//	NULL
4	NULL
m	NULL
itd	NULL
.	NULL

¥	NULL
-aB-globin	NULL
g	NULL
so	NULL
MEL	NULL
‘	NULL
7	NULL
C	NULL
m	NULL
E	NULL
a	NULL
E	NULL
wa	NULL
/	NULL
n	NULL
R	NULL
«	NULL
=	NULL
40	NULL
3	NULL
-	NULL
``	NULL
3	NULL
5	NULL
5	NULL
**	NULL
an	NULL
/	NULL
``	NULL
&	NULL
a	NULL
y	NULL
a	NULL
4	NULL
[	NULL
J—FM	NULL
0	NULL
x	NULL
Treatment	NULL
(	NULL
br	NULL
)	NULL
as	NULL
(	NULL
a	NULL
2	NULL
as	NULL
Treatment	NULL
(	NULL
hr	NULL
)	NULL
Figure	NULL
6	NULL
.	NULL

Restoration	NULL
of	NULL
hemoglobinization	NULL
and	NULL
terminal	NULL
growth	NULL
arrest	NULL
in	NULL
PU.l-transfected	NULL
MEL	NULL
cells	NULL
by	NULL
a	NULL
GATA-1/ER	NULL
fusion	NULL
protein	NULL
.	NULL

MEL	NULL
cells	NULL
(	NULL
broken	NULL
line	NULL
}	NULL
and	NULL
PU.1-transfected	NULL
MEL	NULL
cells	NULL
,	NULL
clone	NULL
605	NULL
{	NULL
A	NULL
]	NULL
and	NULL
two	NULL
representative	NULL
GATA-1/ER	NULL
supertransfectants	NULL
of	NULL
clone	NULL
605	NULL
,	NULL
clones	NULL
12	NULL
{	NULL
B	NULL
)	NULL
and	NULL
13	NULL
{	NULL
C	NULL
)	NULL
{	NULL
solid	NULL
lines	NULL
}	NULL
,	NULL
were	NULL
grown	NULL
without	NULL
(	NULL
#	NULL
]	NULL
or	NULL
with	NULL
5	NULL
mm	NULL
HMBA	NULL
{	NULL
A	NULL
)	NULL
,	NULL
5	NULL
mm	NULL
HMBA	NULL
with	NULL
10	NULL
'm	NULL
B-estradiol	NULL
{	NULL
@	NULL
)	NULL
or	NULL
10	NULL
``	NULL
m	NULL
B-estradiol	NULL
(	NULL
MMI	NULL
)	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
hemoglobinized	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
benzidine	NULL
staining	NULL
as	NULL
described	NULL
in	NULL
Material	NULL
and	NULL
Methods	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
four	NULL
other	NULL
GATA-1/ER	NULL
supertransfectants	NULL
.	NULL

{	NULL
D	NULL
]	NULL
Clone	NULL
605	NULL
and	NULL
clone	NULL
12	NULL
were	NULL
treated	NULL
for	NULL
72	NULL
hr	NULL
with	NULL
10	NULL
m	NULL
B-estradiol	NULL
,	NULL
5	NULL
mm	NULL
HMBA	NULL
,	NULL
or	NULL
both	NULL
as	NULL
indicated	NULL
above	NULL
the	NULL
panel	NULL
.	NULL

B-Globin	NULL
mRNA	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
with	NULL
P-labeled	NULL
B	NULL
major	NULL
globin	NULL
DNA	NULL
.	NULL

The	NULL
lower	NULL
panel	NULL
shows	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
gel	NULL
before	NULL
transfer	NULL
.	NULL

MEL	NULL
cells	NULL
{	NULL
broken	NULL
line	NULL
}	NULL
and	NULL
cells	NULL
of	NULL
clones	NULL
605	NULL
{	NULL
E	NULL
)	NULL
and	NULL
clone	NULL
13	NULL
{	NULL
F	NULL
)	NULL
{	NULL
solid	NULL
lines	NULL
]	NULL
were	NULL
cultured	NULL
as	NULL
in	NULL
A	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
and	NULL
plated	NULL
in	NULL
plasma	NULL
clots	NULL
with	NULL
B-estradiol	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

After	NULL
7	NULL
days	NULL
clots	NULL
were	NULL
removed	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
hematoxylin	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
colonies	NULL
with	NULL
<	NULL
50	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
microscopy	NULL
.	NULL

At	NULL
least	NULL
200	NULL
colonies	NULL
were	NULL
counted	NULL
for	NULL
each	NULL
determination	NULL
.	NULL

roleukemia	NULL
cells	NULL
undergo	NULL
terminal	NULL
differentiation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
is	NULL
also	NULL
true	NULL
during	NULL
normal	NULL
erythropoiesis	NULL
we	NULL
studied	NULL
the	NULL
effects	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
on	NULL
erythropoiesis	NULL
in	NULL
Xenopus	NULL
embryos	NULL
.	NULL

In	NULL
Xenopus	NULL
,	NULL
blood	NULL
is	NULL
derived	NULL
from	NULL
blastomeres	NULL
that	NULL
contribute	NULL
to	NULL
ventral	NULL
me-soderm	NULL
,	NULL
and	NULL
the	NULL
first	NULL
erythrocytes	NULL
differentiate	NULL
in	NULL
the	NULL
'blood	NULL
island	NULL
'	NULL
located	NULL
along	NULL
the	NULL
ventral	NULL
midline	NULL
of	NULL
2-day-old	NULL
embryos	NULL
.	NULL

The	NULL
ventral	NULL
blastomeres	NULL
can	NULL
be	NULL
distinguished	NULL
by	NULL
the	NULL
four-cell	NULL
stage	NULL
;	NULL
the	NULL
dorsal	NULL
/ventral	NULL
axis	NULL
is	NULL
established	NULL
at	NULL
fertilization	NULL
after	NULL
cortical	NULL
rotation	NULL
leading	NULL
to	NULL
the	NULL
differential	NULL
localization	NULL
of	NULL
maternal	NULL
dorsal	NULL
determinants	NULL
(	NULL
and	NULL
pigment	NULL
}	NULL
that	NULL
are	NULL
separated	NULL
physically	NULL
by	NULL
the	NULL
second	NULL
cleavage	NULL
plane	NULL
.	NULL

Therefore	NULL
,	NULL
proteins	NULL
can	NULL
be	NULL
expressed	NULL
ectopically	NULL
during	NULL
blood	NULL
development	NULL
by	NULL
injecting	NULL
fertilized	NULL
eggs	NULL
or	NULL
specific	NULL
cleavage	NULL
stage	NULL
ventral	NULL
blastomeres	NULL
with	NULL
mRNA	NULL
or	NULL
DNA	NULL
expression	NULL
plasmids	NULL
.	NULL

RNA	NULL
encoding	NULL
PU.1	NULL
was	NULL
synthesized	NULL
in	NULL
vitro	NULL
and	NULL
injected	NULL
into	NULL
developing	NULL
Xenopus	NULL
embryos	NULL
.	NULL

Embryos	NULL
developed	NULL
normally	NULL
after	NULL
injecting	NULL
both	NULL
blastomeres	NULL
of	NULL
a	NULL
two-cell	NULL
embryo	NULL
with	NULL
125	NULL
pg	NULL
of	NULL
reverse-strand	NULL
{	NULL
control	NULL
}	NULL
PU.1	NULL
RNA	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
typical	NULL
benzidine	NULL
staining	NULL
of	NULL
blood	NULL
island	NULL
regions	NULL
in	NULL
such	NULL
embryos	NULL
{	NULL
arrow	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
injection	NULL
of	NULL
125	NULL
pg	NULL
of	NULL
PU.1	NULL
RNA	NULL
led	NULL
to	NULL
a	NULL
substantial	NULL
block	NULL
in	NULL
primitive	NULL
erythropoiesis	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
a	NULL
lack	NULL
of	NULL
benzidine	NULL
staining	NULL
regions	NULL
,	NULL
except	NULL
for	NULL
occasional	NULL
small	NULL
patches	NULL
of	NULL
stained	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

These	NULL
embryos	NULL
also	NULL
displayed	NULL
defects	NULL
unrelated	NULL
to	NULL
hematopoiesis	NULL
in	NULL
the	NULL
developing	NULL
dorsal	NULL
axis	NULL
,	NULL
seen	NULL
first	NULL
as	NULL
an	NULL
uneven	NULL
neural	NULL
plate	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
resulting	NULL
in	NULL
abnormally	NULL
shaped	NULL
tails	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
PU.1	NULL
expressed	NULL
specifically	NULL
in	NULL
the	NULL
blood	NULL
island	NULL
region	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
defect	NULL
in	NULL
erythropoiesis	NULL
,	NULL
PU.1	NULL
RNA	NULL
or	NULL
control	NULL
RNAs	NULL
were	NULL
injected	NULL
into	NULL
both	NULL
ventral	NULL
blastomeres	NULL
of	NULL
four-cell	NULL
embryos	NULL
.	NULL

Injection	NULL
of	NULL
as	NULL
much	NULL
as	NULL
1	NULL
ng	NULL
of	NULL
reverse	NULL
strand	NULL
PU.1	NULL
RNA	NULL
into	NULL
ventral	NULL
blastomeres	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
hemoglobin	NULL
production	NULL
{	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Embryos	NULL
injected	NULL
with	NULL
125	NULL
pg	NULL
of	NULL
PU.1	NULL
RNA	NULL
displayed	NULL
a	NULL
lack	NULL
of	NULL
differentiated	NULL
erythro-cytes	NULL
,	NULL
but	NULL
appeared	NULL
otherwise	NULL
normal	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
.	NULL

An	NULL
advantage	NULL
of	NULL
the	NULL
Xenopus	NULL
system	NULL
is	NULL
that	NULL
erythropoiesis	NULL
also	NULL
can	NULL
be	NULL
analyzed	NULL
by	NULL
culturing	NULL
embryo	NULL
explants	NULL
isolated	NULL
from	NULL
the	NULL
presumptive	NULL
ventral	NULL
margin	NULL
zone	NULL
[	NULL
VMZ	NULL
)	NULL
that	NULL
contains	NULL
the	NULL
blood	NULL
progenitors	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
ectopic	NULL
PU.1	NULL
expression	NULL
can	NULL
inhibit	NULL
erythropoiesis	NULL
in	NULL
isolated	NULL
explants	NULL
,	NULL
25	NULL
pg	NULL
of	NULL
a	NULL
plasmid	NULL
encoding	NULL
PU.1	NULL
or	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
injected	NULL
into	NULL
both	NULL
blastomeres	NULL
of	NULL
two-cell	NULL
embryos	NULL
.	NULL

Injected	NULL
plasmids	NULL
are	NULL
not	NULL
transcribed	NULL
until	NULL
the	NULL
midblastula	NULL
transition	NULL
.	NULL

At	NULL
the	NULL
beginning	NULL
of	NULL
gastrulation	NULL
,	NULL
VMZ	NULL
explants	NULL
containing	NULL
primi-	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1405	NULL
Rekhtman	NULL
et	NULL
al	NULL
.	NULL

PU.1	NULL
+	NULL
+	NULL
+	NULL
GATA-	NULL
1	NULL
+	NULL
+	NULL
Control	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
,	NULL
Tin	NULL
Figure	NULL
7	NULL
.	NULL

PU.1	NULL
inhibits	NULL
and	NULL
GATA-1	NULL
restores	NULL
erythroid	NULL
differentiation	NULL
in	NULL
Xenopus	NULL
embryos	NULL
and	NULL
explants	NULL
.	NULL

{	NULL
(	NULL
A-D	NULL
)	NULL
Shown	NULL
are	NULL
representative	NULL
2.5-day	NULL
Xenopus	NULL
embryos	NULL
following	NULL
benzidine	NULL
staining	NULL
to	NULL
visualize	NULL
primitive	NULL
erythropoiesis	NULL
in	NULL
the	NULL
ventral	NULL
blood	NULL
island	NULL
region	NULL
{	NULL
indicated	NULL
by	NULL
arrows	NULL
in	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
embryos	NULL
were	NULL
injected	NULL
with	NULL
125	NULL
pg	NULL
reverse-strand	NULL
control	NULL
RNA	NULL
{	NULL
4	NULL
}	NULL
or	NULL
mRNA	NULL
encoding	NULL
PU.1	NULL
{	NULL
B	NULL
)	NULL
in	NULL
both	NULL
blastomeres	NULL
at	NULL
the	NULL
two-cell	NULL
stage	NULL
.	NULL

Embryos	NULL
shown	NULL
in	NULL
C	NULL
{	NULL
1	NULL
ng	NULL
)	NULL
and	NULL
D	NULL
{	NULL
125	NULL
pg	NULL
)	NULL
had	NULL
been	NULL
injected	NULL
similarly	NULL
,	NULL
except	NULL
that	NULL
the	NULL
mRNA	NULL
was	NULL
targeted	NULL
into	NULL
the	NULL
two	NULL
ventral	NULL
blastomeres	NULL
at	NULL
the	NULL
four-cell	NULL
stage	NULL
.	NULL

{	NULL
E	NULL
,	NULL
F	NULL
)	NULL
Globin	NULL
expression	NULL
in	NULL
VMZ	NULL
explants	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
embryonic	NULL
«	NULL
-globin	NULL
.	NULL

{	NULL
E	NULL
)	NULL
Explants	NULL
were	NULL
cultured	NULL
for	NULL
the	NULL
times	NULL
{	NULL
in	NULL
hr	NULL
}	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

Lysates	NULL
were	NULL
derived	NULL
from	NULL
embryos	NULL
injected	NULL
into	NULL
both	NULL
blastomeres	NULL
at	NULL
the	NULL
two-cell	NULL
stage	NULL
with	NULL
25	NULL
pg	NULL
of	NULL
either	NULL
a	NULL
control	NULL
{	NULL
C	NULL
)	NULL
CMV	NULL
expression	NULL
plasmid	NULL
,	NULL
or	NULL
the	NULL
same	NULL
plasmid	NULL
containing	NULL
the	NULL
PU.1	NULL
cDNA	NULL
{	NULL
PU	NULL
}	NULL
.	NULL

The	NULL
lysate	NULL
in	NULL
lane	NULL
WE	NULL
was	NULL
from	NULL
an	NULL
un-injected	NULL
80-hr	NULL
whole	NULL
embryo	NULL
.	NULL

Each	NULL
sample	NULL
contains	NULL
proteins	NULL
from	NULL
six	NULL
VMZ	NULL
explants	NULL
,	NULL
derived	NULL
from	NULL
two	NULL
independent	NULL
experi-ments	NULL
.	NULL

{	NULL
F	NULL
)	NULL
For	NULL
each	NULL
sample	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
10	NULL
VMZ	NULL
explants	NULL
isolated	NULL
from	NULL
embryos	NULL
previously	NULL
injected	NULL
at	NULL
the	NULL
four-cell	NULL
stage	NULL
with	NULL
RNA	NULL
into	NULL
both	NULL
ventral	NULL
blastomeres	NULL
.	NULL

Embryos	NULL
were	NULL
injected	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
PU.1	NULL
,	NULL
GATA-1	NULL
,	NULL
reverse-strand	NULL
PU.1	NULL
{	NULL
PU.lrs	NULL
)	NULL
,	NULL
or	NULL
a	NULL
frameshift	NULL
mutant	NULL
form	NULL
of	NULL
GATA-1	NULL
that	NULL
encodes	NULL
a	NULL
nonfunctional	NULL
protein	NULL
(	NULL
G1lfs	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
any	NULL
nonspecific	NULL
effects	NULL
of	NULL
RNA	NULL
injection	NULL
,	NULL
a	NULL
total	NULL
of	NULL
350	NULL
pg	NULL
mRNA	NULL
was	NULL
injected	NULL
into	NULL
each	NULL
blastomere	NULL
,	NULL
supplemented	NULL
with	NULL
PU.1rs	NULL
or	NULL
Glfs	NULL
as	NULL
required	NULL
.	NULL

{	NULL
Lane	NULL
1	NULL
]	NULL
250	NULL
pg	NULL
PU.1	NULL
+	NULL
100	NULL
pg	NULL
CGlfs	NULL
;	NULL
{	NULL
lane	NULL
2	NULL
)	NULL
250	NULL
pg	NULL
PU.1	NULL
+	NULL
100	NULL
pg	NULL
GATA-1	NULL
;	NULL
{	NULL
lane	NULL
3	NULL
)	NULL
:	NULL
250	NULL
pg	NULL
GATA-1	NULL
+	NULL
100	NULL
pg	NULL
Glfs	NULL
;	NULL
{	NULL
lane	NULL
4	NULL
)	NULL
:	NULL
250	NULL
pg	NULL
PU.1rs	NULL
+	NULL
100	NULL
pg	NULL
Glfs	NULL
;	NULL
{	NULL
lane	NULL
5	NULL
)	NULL
the	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
from	NULL
an	NULL
independent	NULL
experiment	NULL
.	NULL

(	NULL
Lower	NULL
)	NULL
Coomassie	NULL
Blue	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
demonstrates	NULL
equal	NULL
loading	NULL
of	NULL
total	NULL
protein	NULL
for	NULL
each	NULL
lane	NULL
.	NULL

tive	NULL
erythroid	NULL
progenitors	NULL
were	NULL
isolated	NULL
and	NULL
allowed	NULL
to	NULL
develop	NULL
in	NULL
culture	NULL
.	NULL

At	NULL
various	NULL
times	NULL
,	NULL
explants	NULL
were	NULL
harvested	NULL
and	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
globin	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

7E	NULL
)	NULL
.	NULL

By	NULL
48	NULL
hr	NULL
,	NULL
when	NULL
globin	NULL
was	NULL
detected	NULL
in	NULL
control	NULL
explants	NULL
,	NULL
there	NULL
was	NULL
significantly	NULL
less	NULL
globin	NULL
in	NULL
the	NULL
explants	NULL
injected	NULL
with	NULL
the	NULL
PU.1	NULL
expression	NULL
plasmid	NULL
.	NULL

By	NULL
80	NULL
hr	NULL
,	NULL
the	NULL
control	NULL
explants	NULL
expressed	NULL
abundant	NULL
globin	NULL
,	NULL
whereas	NULL
those	NULL
expressing	NULL
ectopic	NULL
PU.1	NULL
were	NULL
negative	NULL
for	NULL
globin	NULL
.	NULL

PU.1	NULL
appears	NULL
to	NULL
inhibit	NULL
transcription	NULL
of	NULL
the	NULL
globin	NULL
gene	NULL
as	NULL
determined	NULL
by	NULL
RT-PCR	NULL
experiments	NULL
for	NULL
globin	NULL
mRNA	NULL
(	NULL
{	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Globin	NULL
production	NULL
also	NULL
was	NULL
blocked	NULL
in	NULL
isolated	NULL
VMZ	NULL
explants	NULL
after	NULL
injecting	NULL
250	NULL
pg	NULL
of	NULL
PU.1	NULL
RNA	NULL
into	NULL
the	NULL
two	NULL
ventral	NULL
blastomeres	NULL
at	NULL
the	NULL
four-cell	NULL
stage	NULL
[	NULL
Fig	NULL
.	NULL

7F	NULL
,	NULL
lanes	NULL
1,5	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
coinjection	NULL
of	NULL
100	NULL
pg	NULL
of	NULL
RNA	NULL
encoding	NULL
Xenopus	NULL
GATA-1	NULL
is	NULL
sufficient	NULL
to	NULL
rescue	NULL
erythropoiesis	NULL
,	NULL
assayed	NULL
by	NULL
globin	NULL
produc-	NULL
1406	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
tion	NULL
(	NULL
Fig	NULL
.	NULL

7F	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Rescue	NULL
of	NULL
blood	NULL
island	NULL
development	NULL
in	NULL
whole	NULL
embryos	NULL
coinjected	NULL
with	NULL
PU.1	NULL
and	NULL
GATA-1l	NULL
RNA	NULL
into	NULL
ventral	NULL
blastomeres	NULL
also	NULL
was	NULL
demonstrated	NULL
by	NULL
benzidine	NULL
staining	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
can	NULL
determine	NULL
the	NULL
outcome	NULL
of	NULL
erythroid	NULL
differentiation	NULL
during	NULL
normal	NULL
development	NULL
.	NULL

Discussion	NULL
Previous	NULL
studies	NULL
with	NULL
MEL	NULL
cells	NULL
and	NULL
other	NULL
cell	NULL
culture	NULL
models	NULL
showed	NULL
that	NULL
PU.1	NULL
can	NULL
block	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
PU.1	NULL
interferes	NULL
with	NULL
erythroid	NULL
differentiation	NULL
,	NULL
we	NULL
investigated	NULL
potential	NULL
interactions	NULL
between	NULL
PU.1	NULL
and	NULL
several	NULL
erythroid-specific	NULL
transcription	NULL
factors	NULL
.	NULL

Among	NULL
the	NULL
factors	NULL
tested	NULL
,	NULL
GATA-1	NULL
showed	NULL
very	NULL
strong	NULL
binding	NULL
with	NULL
PU.1	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
interact	NULL
directly	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
and	NULL
that	NULL
the	NULL
interaction	NULL
leads	NULL
to	NULL
repression	NULL
of	NULL
GATA-1-mediated	NULL
transcriptional	NULL
activation	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
oppose	NULL
each	NULL
other	NULL
's	NULL
biological	NULL
activities	NULL
in	NULL
both	NULL
normal	NULL
and	NULL
leukemic	NULL
erythroid	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
can	NULL
antagonize	NULL
each	NULL
other	NULL
's	NULL
actions	NULL
by	NULL
binding	NULL
to	NULL
one	NULL
another	NULL
and	NULL
altering	NULL
some	NULL
aspect	NULL
of	NULL
their	NULL
functions	NULL
as	NULL
transcription	NULL
factors	NULL
.	NULL

Mechanism	NULL
of	NULL
PU.1-mediated	NULL
repression	NULL
of	NULL
GATA-1	NULL
The	NULL
results	NULL
reported	NULL
here	NULL
show	NULL
that	NULL
PU.1	NULL
binds	NULL
to	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
of	NULL
GATA-1	NULL
.	NULL

This	NULL
region	NULL
of	NULL
GATA-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
DNA	NULL
(	NULL
Martin	NULL
and	NULL
Orkin	NULL
1990	NULL
}	NULL
.	NULL

It	NULL
also	NULL
participates	NULL
in	NULL
interactions	NULL
with	NULL
several	NULL
other	NULL
proteins	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
including	NULL
FOG	NULL
(	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
,	NULL
CREB-binding	NULL
protein	NULL
(	NULL
CBP	NULL
;	NULL
Blobel	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
}	NULL
,	NULL
EKLF	NULL
,	NULL
and	NULL
Spl	NULL
stimulate	NULL
GATA-1	NULL
transcriptional	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
two	NULL
examples	NULL
of	NULL
repression	NULL
of	NULL
GATA	NULL
factors	NULL
have	NULL
been	NULL
described	NULL
that	NULL
involve	NULL
interactions	NULL
with	NULL
the	NULL
finger	NULL
region	NULL
.	NULL

Inhibition	NULL
of	NULL
a	NULL
Drosophila	NULL
GATA	NULL
ho-molog	NULL
,	NULL
Pannier	NULL
,	NULL
by	NULL
U-shaped	NULL
occurs	NULL
through	NULL
interaction	NULL
with	NULL
the	NULL
amino	NULL
finger	NULL
(	NULL
Haenlin	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
GATA-1	NULL
by	NULL
the	NULL
estrogen	NULL
receptor	NULL
appears	NULL
to	NULL
involve	NULL
both	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
and	NULL
another	NULL
region	NULL
of	NULL
GATA-1l	NULL
(	NULL
Blobel	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
underlying	NULL
stimulation	NULL
or	NULL
repression	NULL
of	NULL
GATA-1	NULL
activity	NULL
by	NULL
binding	NULL
of	NULL
these	NULL
various	NULL
proteins	NULL
to	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
are	NULL
not	NULL
known	NULL
.	NULL

Several	NULL
different	NULL
mechanisms	NULL
can	NULL
be	NULL
envisaged	NULL
for	NULL
how	NULL
binding	NULL
of	NULL
PU.1	NULL
to	NULL
the	NULL
finger	NULL
region	NULL
inhibits	NULL
GATA-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

Any	NULL
proposed	NULL
mechanism	NULL
must	NULL
account	NULL
for	NULL
our	NULL
finding	NULL
that	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
PU.1	NULL
is	NULL
required	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
inhibit	NULL
-dependent	NULL
transcription	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
blocking	NULL
MEL	NULL
cell	NULL
differentiation	NULL
,	NULL
although	NULL
not	NULL
for	NULL
binding	NULL
to	NULL
GATA-1	NULL
.	NULL

This	NULL
finding	NULL
makes	NULL
it	NULL
unlikely	NULL
that	NULL
PU.1	NULL
represses	NULL
GATA-1	NULL
activity	NULL
by	NULL
simply	NULL
preventing	NULL
its	NULL
binding	NULL
to	NULL
DNA	NULL
or	NULL
required	NULL
cofactors	NULL
that	NULL
also	NULL
bind	NULL
to	NULL
the	NULL
GATA-1	NULL
zinc	NULL
finger	NULL
region	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
view	NULL
,	NULL
GATA-1	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
target	NULL
DNA	NULL
sites	NULL
[	NULL
Strauss	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
;	NULL
Reddy	NULL
and	NULL
Shen	NULL
1993	NULL
)	NULL
and	NULL
several	NULL
cofactors	NULL
(	NULL
Osada	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
;	NULL
Blobel	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
)	NULL
in	NULL
MEL	NULL
cells	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
found	NULL
that	NULL
CBP	NULL
and	NULL
FOG	NULL
binding	NULL
to	NULL
GATA-1	NULL
was	NULL
not	NULL
diminished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
excess	NULL
PU.1	NULL
in	NULL
vitro	NULL
{	NULL
(	NULL
N.	NULL
Rekhtman	NULL
and	NULL
AL	NULL
.	NULL

Skoultchi	NULL
,	NULL
unpubl	NULL
.	NULL
)	NULL

.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
GATA-1	NULL
may	NULL
be	NULL
able	NULL
to	NULL
assemble	NULL
with	NULL
associated	NULL
proteins	NULL
on	NULL
DNA	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PU.1	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
a	NULL
more	NULL
likely	NULL
mechanism	NULL
involves	NULL
association	NULL
of	NULL
PU.1	NULL
with	NULL
the	NULL
assembled	NULL
GATA-1	NULL
protein	NULL
complex	NULL
on	NULL
DNA	NULL
and	NULL
repression	NULL
of	NULL
its	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
model	NULL
binding	NULL
to	NULL
the	NULL
GATA-1	NULL
finger	NULL
region	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
PU.1	NULL
Ets	NULL
domain	NULL
,	NULL
whereas	NULL
the	NULL
PU.1	NULL
transactivation	NULL
domain	NULL
would	NULL
be	NULL
needed	NULL
to	NULL
recruit	NULL
other	NULL
protein	NULL
factors	NULL
or	NULL
to	NULL
inhibit	NULL
activities	NULL
necessary	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
may	NULL
be	NULL
relevant	NULL
that	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
PU.1	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
interact	NULL
with	NULL
both	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
RB	NULL
)	NULL
and	NULL
TATA-binding	NULL
protein	NULL
{	NULL
TBP	NULL
)	NULL
(	NULL
Hagemeier	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Tethering	NULL
of	NULL
RB	NULL
to	NULL
promoters	NULL
through	NULL
protein-protein	NULL
interactions	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
transcriptional	NULL
repression	NULL
(	NULL
Weintraub	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
or	NULL
in	NULL
ad-dition	NULL
,	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
PU.1	NULL
might	NULL
contact	NULL
TBP	NULL
and	NULL
cause	NULL
inhibition	NULL
of	NULL
transcription	NULL
initiation	NULL
by	NULL
GATA-1	NULL
.	NULL

Although	NULL
PU.1	NULL
has	NULL
most	NULL
often	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
containing	NULL
PU.1-binding	NULL
sites	NULL
,	NULL
a	NULL
few	NULL
instances	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
which	NULL
PU.1	NULL
represses	NULL
transcription	NULL
(	NULL
Borras	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
;	NULL
Lopez-Rodriguez	NULL
and	NULL
Corbi	NULL
1997	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
reporter	NULL
constructs	NULL
used	NULL
in	NULL
the	NULL
current	NULL
work	NULL
do	NULL
not	NULL
contain	NULL
PU.1	NULL
consensus-binding	NULL
sequences	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
GATA-1-binding	NULL
sites	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
repression	NULL
of	NULL
GATA-1	NULL
activity	NULL
by	NULL
PU.1	NULL
can	NULL
occur	NULL
without	NULL
PU.1	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
that	NULL
in	NULL
these	NULL
experiments	NULL
PU.1	NULL
is	NULL
tethered	NULL
through	NULL
its	NULL
strong	NULL
interaction	NULL
with	NULL
GATA-1	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
quite	NULL
possible	NULL
that	NULL
in	NULL
some	NULL
cases	NULL
repression	NULL
of	NULL
GATA-1	NULL
activity	NULL
by	NULL
PU.1	NULL
occurs	NULL
on	NULL
genes	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
proteins	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
GATA-1	NULL
and	NULL
PU.1	NULL
sites	NULL
have	NULL
been	NULL
found	NULL
in	NULL
close	NULL
proximity	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
of	NULL
two	NULL
erythoid-specific	NULL
genes	NULL
(	NULL
Galson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Nemoto	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

Mechanism	NULL
of	NULL
PU.1-mediated	NULL
block	NULL
to	NULL
differentiation	NULL
in	NULL
erythroleukemia	NULL
The	NULL
results	NULL
reported	NULL
here	NULL
show	NULL
that	NULL
PU.1	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
block	NULL
erythroid	NULL
differentiation	NULL
in	NULL
both	NULL
MEL	NULL
cells	NULL
and	NULL
Xenopus	NULL
embryos	NULL
,	NULL
and	NULL
that	NULL
in	NULL
both	NULL
situations	NULL
increasing	NULL
the	NULL
amount	NULL
of	NULL
GATA-1	NULL
relative	NULL
to	NULL
PU.1	NULL
relieves	NULL
the	NULL
block	NULL
and	NULL
restores	NULL
the	NULL
differentiation	NULL
process	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
GATA-1	NULL
is	NULL
the	NULL
principal	NULL
target	NULL
of	NULL
the	NULL
PU.1-mediated	NULL
block	NULL
to	NULL
differentiation	NULL
in	NULL
the	NULL
erythroleu-kemic	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
do	NULL
not	NULL
exclude	NULL
other	NULL
actions	NULL
of	NULL
PU.1	NULL
in	NULL
the	NULL
erythroleukemia	NULL
.	NULL

A	NULL
recently	NULL
identified	NULL
PU.1	NULL
target	NULL
gene	NULL
that	NULL
is	NULL
clearly	NULL
relevant	NULL
to	NULL
erythroleukemia	NULL
is	NULL
another	NULL
ets	NULL
family	NULL
member	NULL
gene	NULL
fli-1	NULL
.	NULL

The	NULL
fli-1	NULL
locus	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
preferred	NULL
viral	NULL
integration	NULL
site	NULL
in	NULL
SFFV-independent	NULL
Interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
erythroleukemias	NULL
induced	NULL
in	NULL
newborn	NULL
mice	NULL
by	NULL
F-MuLV	NULL
,	NULL
the	NULL
helper	NULL
component	NULL
of	NULL
Friend	NULL
virus	NULL
{	NULL
Ben-David	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
)	NULL
.	NULL

Fli-1	NULL
transcription	NULL
is	NULL
stimulated	NULL
by	NULL
PU.1	NULL
and	NULL
Fli-1	NULL
can	NULL
also	NULL
block	NULL
MEL	NULL
cell	NULL
differentiation	NULL
[	NULL
Starck	NULL
et	NULL
al	NULL
.	NULL

1999	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
fli-1	NULL
may	NULL
be	NULL
an	NULL
effector	NULL
gene	NULL
,	NULL
downstream	NULL
of	NULL
PU.1	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
fli-1	NULL
promoter	NULL
con-tains	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
multiple	NULL
PU.l-binding	NULL
sites	NULL
,	NULL
a	NULL
GATA-1	NULL
site	NULL
(	NULL
Starck	NULL
et	NULL
al	NULL
.	NULL

1999	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Fli-1	NULL
expression	NULL
could	NULL
be	NULL
modulated	NULL
by	NULL
GATA-1	NULL
,	NULL
although	NULL
the	NULL
role	NULL
of	NULL
the	NULL
GATA-1	NULL
site	NULL
in	NULL
the	NULL
f1i-1	NULL
promoter	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
present	NULL
.	NULL

It	NULL
is	NULL
also	NULL
noteworthy	NULL
that	NULL
we	NULL
found	NULL
that	NULL
Fli-1	NULL
and	NULL
GATA-1	NULL
interact	NULL
in	NULL
vitro	NULL
,	NULL
albeit	NULL
weakly	NULL
compared	NULL
to	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
.	NULL

Fli-1	NULL
binding	NULL
to	NULL
GATA-1	NULL
might	NULL
amplify	NULL
the	NULL
affect	NULL
of	NULL
PU.1	NULL
on	NULL
GATA-1	NULL
.	NULL

Another	NULL
possible	NULL
mechanism	NULL
of	NULL
the	NULL
PU.l-mediated	NULL
block	NULL
to	NULL
erythroid	NULL
differentiation	NULL
might	NULL
involve	NULL
the	NULL
binding	NULL
of	NULL
PU.1	NULL
to	NULL
other	NULL
erythroid	NULL
transcription	NULL
factors	NULL
.	NULL

Results	NULL
presented	NULL
here	NULL
show	NULL
that	NULL
in	NULL
vitro	NULL
PU.1	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
GATA-2	NULL
and	NULL
EKLF	NULL
.	NULL

EKLEF	NULL
is	NULL
an	NULL
erythroid-specific	NULL
factor	NULL
that	NULL
is	NULL
required	NULL
for	NULL
expression	NULL
of	NULL
-globin	NULL
(	NULL
Shivdasani	NULL
and	NULL
Orkin	NULL
1996	NULL
)	NULL
and	NULL
possibly	NULL
other	NULL
genes	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Binding	NULL
of	NULL
PU.1	NULL
to	NULL
EKLF	NULL
,	NULL
although	NULL
much	NULL
weaker	NULL
than	NULL
to	NULL
GATA-1	NULL
,	NULL
could	NULL
have	NULL
similar	NULL
consequences	NULL
in	NULL
inhibiting	NULL
erythroid	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
we	NULL
think	NULL
that	NULL
GATA-2	NULL
is	NULL
unlikely	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
PU.1-mediated	NULL
block	NULL
to	NULL
differentiation	NULL
in	NULL
MEL	NULL
cells	NULL
because	NULL
these	NULL
cells	NULL
have	NULL
only	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
GATA-2	NULL
mRNA	NULL
(	NULL
Leonard	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Other	NULL
proposed	NULL
targets	NULL
of	NULL
interaction	NULL
with	NULL
PU.1	NULL
in	NULL
MEL	NULL
cells	NULL
include	NULL
an	NULL
RNA-binding	NULL
protein	NULL
p54	NULL
``	NULL
*	NULL
``	NULL
(	NULL
Hallier	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
,	NULL
a	NULL
potential	NULL
splicing	NULL
factor	NULL
TLS	NULL
(	NULL
Hallier	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
)	NULL
,	NULL
and	NULL
steroid	NULL
hormone	NULL
and	NULL
vitamin	NULL
receptors	NULL
(	NULL
Gauthier	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
,	NULL
but	NULL
the	NULL
contributions	NULL
of	NULL
such	NULL
interactions	NULL
to	NULL
the	NULL
differentiation	NULL
block	NULL
remain	NULL
to	NULL
be	NULL
evaluated	NULL
.	NULL

The	NULL
results	NULL
reported	NULL
here	NULL
also	NULL
show	NULL
with	NULL
PU.1-blocked	NULL
MEL	NULL
cell	NULL
transfectants	NULL
,	NULL
that	NULL
simply	NULL
shifting	NULL
the	NULL
balance	NULL
in	NULL
favor	NULL
of	NULL
GATA-1	NULL
by	NULL
supertransfecting	NULL
with	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
conditionally	NULL
active	NULL
GATA-1	NULL
not	NULL
only	NULL
restores	NULL
hemoglobin	NULL
synthesis	NULL
but	NULL
also	NULL
the	NULL
ability	NULL
to	NULL
undergo	NULL
terminal	NULL
cell	NULL
division	NULL
.	NULL

We	NULL
have	NULL
performed	NULL
similar	NULL
experiments	NULL
in	NULL
MEL	NULL
cells	NULL
containing	NULL
the	NULL
GATA-1/ER	NULL
fusion	NULL
protein	NULL
but	NULL
without	NULL
an	NULL
exogenous	NULL
PU.1	NULL
gene	NULL
and	NULL
found	NULL
that	NULL
estrogen	NULL
treatment	NULL
alone	NULL
can	NULL
induce	NULL
80-90	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
undergo	NULL
differentiation	NULL
and	NULL
terminal	NULL
cell	NULL
division	NULL
.	NULL

[	NULL
F.	NULL
Radparvar	NULL
and	NULL
AI	NULL
.	NULL

Skoultchi	NULL
,	NULL
unpubl	NULL
.	NULL
}	NULL

.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
it	NULL
may	NULL
be	NULL
possible	NULL
to	NULL
reverse	NULL
uncontrolled	NULL
proliferation	NULL
in	NULL
tumor	NULL
cells	NULL
by	NULL
introducing	NULL
into	NULL
them	NULL
a	NULL
single	NULL
gene	NULL
encoding	NULL
the	NULL
transcription	NULL
factor	NULL
that	NULL
normally	NULL
regulates	NULL
their	NULL
differentiation	NULL
process	NULL
.	NULL

Do	NULL
PU.1	NULL
and	NULL
GATA	NULL
factors	NULL
interact	NULL
during	NULL
normal	NULL
development	NULL
?	NULL

Although	NULL
the	NULL
results	NULL
reported	NULL
here	NULL
clearly	NULL
show	NULL
that	NULL
PU	NULL
.	NULL
]	NULL

can	NULL
interact	NULL
with	NULL
several	NULL
GATA	NULL
factors	NULL
in	NULL
vitro	NULL
and	NULL
that	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
interact	NULL
in	NULL
vivo	NULL
in	NULL
erythroleukemia	NULL
cells	NULL
,	NULL
we	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
these	NULL
interactions	NULL
occur	NULL
during	NULL
normal	NULL
development	NULL
.	NULL

The	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
PU.1	NULL
and	NULL
GATA	NULL
factors	NULL
interact	NULL
during	NULL
normal	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1407	NULL
Rekhtman	NULL
et	NULL
al	NULL
.	NULL

development	NULL
may	NULL
be	NULL
basic	NULL
to	NULL
our	NULL
understanding	NULL
of	NULL
lineage	NULL
commitment	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

Current	NULL
views	NULL
of	NULL
lineage	NULL
commitment	NULL
processes	NULL
suggest	NULL
that	NULL
such	NULL
decisions	NULL
require	NULL
both	NULL
increased	NULL
expression	NULL
of	NULL
lineage-specific	NULL
genes	NULL
as	NULL
well	NULL
as	NULL
decreased	NULL
expression	NULL
of	NULL
other	NULL
genes	NULL
that	NULL
are	NULL
not	NULL
needed	NULL
in	NULL
or	NULL
are	NULL
not	NULL
compatible	NULL
with	NULL
individual	NULL
differentiation	NULL
programs	NULL
{	NULL
Cross	NULL
and	NULL
Enver	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
results	NULL
described	NULL
here	NULL
using	NULL
the	NULL
Xenopus	NULL
embryo	NULL
system	NULL
show	NULL
that	NULL
PU.l1	NULL
and	NULL
GATA-1	NULL
can	NULL
antagonize	NULL
each	NULL
others	NULL
actions	NULL
in	NULL
normal	NULL
erythropoiesis	NULL
.	NULL

Thus	NULL
,	NULL
if	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
are	NULL
normally	NULL
expressed	NULL
in	NULL
early	NULL
hematopoietic	NULL
progenitors	NULL
,	NULL
their	NULL
relative	NULL
levels	NULL
could	NULL
regulate	NULL
lineage	NULL
commitment	NULL
decisions	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
that	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
are	NULL
coexpressed	NULL
in	NULL
certain	NULL
hematopoietic	NULL
cells	NULL
as	NULL
their	NULL
mRNAs	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
early	NULL
erythroid	NULL
precursors	NULL
and	NULL
also	NULL
in	NULL
multipotent	NULL
progenitors	NULL
(	NULL
Cheng	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
.	NULL

The	NULL
two	NULL
proteins	NULL
were	NULL
also	NULL
detected	NULL
in	NULL
mature	NULL
mast	NULL
cells	NULL
(	NULL
Henkel	NULL
and	NULL
Bro-lon	NULL
1994	NULL
)	NULL
.	NULL

An	NULL
even	NULL
more	NULL
likely	NULL
possibility	NULL
for	NULL
interaction	NULL
during	NULL
normal	NULL
development	NULL
may	NULL
be	NULL
between	NULL
PU.1	NULL
and	NULL
GATA-2	NULL
.	NULL

GATA-2	NULL
is	NULL
expressed	NULL
more	NULL
widely	NULL
than	NULL
GATA-1	NULL
and	NULL
it	NULL
is	NULL
thought	NULL
that	NULL
GATA-2	NULL
functions	NULL
very	NULL
early	NULL
in	NULL
hematopoietic	NULL
cell	NULL
development	NULL
and	NULL
proliferation	NULL
(	NULL
Shivdasani	NULL
and	NULL
Orkin	NULL
1996	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
GATA-2	NULL
null	NULL
mice	NULL
and	NULL
embryonic	NULL
stem	NULL
{	NULL
ES	NULL
)	NULL
cells	NULL
support	NULL
this	NULL
view	NULL
,	NULL
indicating	NULL
that	NULL
GATA-2	NULL
may	NULL
be	NULL
needed	NULL
for	NULL
generation	NULL
of	NULL
many	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
hematopoietic	NULL
progenitors	NULL
(	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
)	NULL
.	NULL

Thus	NULL
a	NULL
functional	NULL
interaction	NULL
could	NULL
occur	NULL
between	NULL
PU.1	NULL
and	NULL
GATA-2	NULL
in	NULL
erythroid	NULL
,	NULL
myeloid	NULL
,	NULL
or	NULL
lymphoid	NULL
lineage	NULL
determination	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
consequences	NULL
of	NULL
PU.1-GATA	NULL
factor	NULL
interactions	NULL
need	NULL
not	NULL
always	NULL
result	NULL
in	NULL
inhibition	NULL
of	NULL
target	NULL
promoter	NULL
function	NULL
.	NULL

In	NULL
at	NULL
least	NULL
one	NULL
instance	NULL
,	NULL
PU.1	NULL
and	NULL
GATA	NULL
factors	NULL
were	NULL
shown	NULL
to	NULL
collaborate	NULL
to	NULL
stimulate	NULL
transcription	NULL
of	NULL
a	NULL
target	NULL
gene	NULL
containing	NULL
adjacent	NULL
PU.1	NULL
and	NULL
GATA	NULL
binding	NULL
sites	NULL
(	NULL
Henkel	NULL
and	NULL
Brown	NULL
1991	NULL
)	NULL
.	NULL

Both	NULL
PU.1	NULL
and	NULL
GATA-2	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
block	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
.	NULL

This	NULL
could	NULL
suggest	NULL
that	NULL
these	NULL
two	NULL
factors	NULL
interact	NULL
and	NULL
collaborate	NULL
to	NULL
stimulate	NULL
cell	NULL
division	NULL
in	NULL
early	NULL
erythroid	NULL
progenitors	NULL
.	NULL

The	NULL
association	NULL
of	NULL
PU.1	NULL
and	NULL
GATA	NULL
factors	NULL
in	NULL
hematopoietic	NULL
cells	NULL
and	NULL
the	NULL
consequences	NULL
of	NULL
such	NULL
interactions	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
In	NULL
vitro	NULL
protein	NULL
interaction	NULL
studies	NULL
Glutathione	NULL
S-transferase	NULL
fusion	NULL
proteins	NULL
were	NULL
prepared	NULL
by	NULL
standard	NULL
procedures	NULL
.	NULL

Purity	NULL
of	NULL
the	NULL
GST	NULL
fusion	NULL
proteins	NULL
was	NULL
analyzed	NULL
by	NULL
boiling	NULL
proteins	NULL
for	NULL
5	NULL
min	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
[	NULL
60	NULL
mm	NULL
Tris	NULL
[	NULL
pH	NULL
6.8	NULL
)	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
mm	NULL
DTT	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.001	NULL
%	NULL
bromphenol	NULL
blue	NULL
]	NULL
,	NULL
separating	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Coomassie	NULL
Blue	NULL
staining	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
each	NULL
purified	NULL
GST	NULL
fusion	NULL
protein	NULL
was	NULL
estimated	NULL
by	NULL
comparison	NULL
to	NULL
several	NULL
amounts	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
also	NULL
present	NULL
on	NULL
the	NULL
gels	NULL
.	NULL

The	NULL
GST	NULL
fusion	NULL
protein	NULL
constructs	NULL
included	NULL
GATA-1	NULL
and	NULL
GATA-1	NULL
mutants	NULL
,	NULL
PU.1	NULL
kindly	NULL
provided	NULL
by	NULL
Y.K	NULL
.	NULL

Fung	NULL
{	NULL
USC	NULL
,	NULL
Los	NULL
Angeles	NULL
)	NULL
and	NULL
GUK	NULL
a	NULL
gift	NULL
from	NULL
R.A.	NULL
DePinho	NULL
(	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MAJ.	NULL
proteins	NULL
were	NULL
prepared	NULL
by	NULL
in	NULL
vitro	NULL
1408	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
transcription/translation	NULL
using	NULL
a	NULL
coupled	NULL
TnT	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
[	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Plasmids	NULL
used	NULL
included	NULL
pGEM-PU.1	NULL
{	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
]	NULL
for	NULL
full-length	NULL
PU.1	NULL
,	NULL
PU.1	NULL
{	NULL
ADBD	NULL
]	NULL
constructed	NULL
by	NULL
cloning	NULL
the	NULL
KpnI	NULL
fragment	NULL
from	NULL
pGEM-PU.1	NULL
into	NULL
the	NULL
KpnI	NULL
site	NULL
of	NULL
pBluescript	NULL
{	NULL
pBSK	NULL
,	NULL
Stratagene	NULL
}	NULL
,	NULL
PU.1	NULL
{	NULL
APEST	NULL
)	NULL
{	NULL
Klemsz	NULL
and	NULL
Maki	NULL
1996	NULL
)	NULL
subcloned	NULL
in	NULL
EcoRI	NULL
site	NULL
of	NULL
pBSK	NULL
,	NULL
pBKS-PU.1	NULL
{	NULL
ANN	NULL
)	NULL
called	NULL
here	NULL
ATAD	NULL
,	NULL
{	NULL
ANP	NULL
}	NULL
,	NULL
{	NULL
ANS	NULL
)	NULL
(	NULL
Klemsz	NULL
and	NULL
Maki	NULL
1996	NULL
]	NULL
kindly	NULL
provided	NULL
by	NULL
M.J.	NULL
Klemsz	NULL
,	NULL
pBSK-GATA-1	NULL
{	NULL
AN	NULL
)	NULL
[	NULL
Blobel	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
)	NULL
a	NULL
gift	NULL
from	NULL
G.A	NULL
.	NULL

Blobel	NULL
,	NULL
GATA-1	NULL
{	NULL
AC	NULL
)	NULL
and	NULL
GATA-1	NULL
{	NULL
Afingers	NULL
)	NULL
generated	NULL
by	NULL
subcloning	NULL
the	NULL
respective	NULL
coding	NULL
sequences	NULL
derived	NULL
from	NULL
pXM-GATA-I1	NULL
{	NULL
AC	NULL
)	NULL
{	NULL
(	NULL
Martin	NULL
and	NULL
Orkin	NULL
1990	NULL
]	NULL
and	NULL
pGEX-2T-GATA-l-Afingers	NULL
(	NULL
Merika	NULL
and	NULL
Orkin	NULL
1995	NULL
)	NULL
into	NULL
pBSK	NULL
,	NULL
p45	NULL
NF-E2	NULL
{	NULL
Andrews	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
]	NULL
and	NULL
FOG	NULL
{	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
generated	NULL
by	NULL
subcloning	NULL
the	NULL
respective	NULL
coding	NULL
sequences	NULL
into	NULL
the	NULL
pBSK	NULL
vector	NULL
,	NULL
pL28-Spi-B	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
D.G	NULL
.	NULL

Tenen	NULL
{	NULL
Beth	NULL
Israel	NULL
Deaconness	NULL
Medical	NULL
Center	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
}	NULL
;	NULL
pBKS-Fli-1	NULL
,	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
A.	NULL
Bernstein	NULL
{	NULL
(	NULL
Mount	NULL
Sinai	NULL
Hospital	NULL
,	NULL
Toronto	NULL
,	NULL
Canada	NULL
)	NULL
;	NULL
pPET8C-GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
and	NULL
GATA-3	NULL
and	NULL
pBSK-EKLF	NULL
generously	NULL
provided	NULL
by	NULL
M.	NULL
Merika	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
{	NULL
2	NULL
ug	NULL
)	NULL
immobilized	NULL
on	NULL
beads	NULL
and	NULL
amounts	NULL
of	NULL
*°S-labeled	NULL
proteins	NULL
quantitated	NULL
by	NULL
fluorography	NULL
were	NULL
mixed	NULL
in	NULL
400	NULL
ul	NULL
of	NULL
EBC	NULL
buffer	NULL
[	NULL
120	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
m	NULL
Tris-HCl	NULL
{	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
1	NULL
mm	NULL
ZnCl	NULL
;	NULL
,	NULL
,	NULL
protease	NULL
inhibitors	NULL
]	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
hr	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
glutathione	NULL
Seph-arose	NULL
used	NULL
in	NULL
each	NULL
binding	NULL
reaction	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
adding	NULL
an	NULL
appropriate	NULL
amount	NULL
of	NULL
beads	NULL
without	NULL
bound	NULL
proteins	NULL
.	NULL

Beads	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
with	NULL
EBC	NULL
buffer	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
NaCl	NULL
in	NULL
the	NULL
final	NULL
wash	NULL
was	NULL
increased	NULL
to	NULL
500	NULL
mm	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
released	NULL
from	NULL
the	NULL
beads	NULL
by	NULL
boiling	NULL
for	NULL
5	NULL
min	NULL
in	NULL
40	NULL
pl	NULL
of	NULL
sample	NULL
buffer	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
fluorography	NULL
.	NULL

To	NULL
generate	NULL
proteins	NULL
free	NULL
of	NULL
the	NULL
GST	NULL
moiety	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
purified	NULL
GST	NULL
fusion	NULL
proteins	NULL
immobilized	NULL
on	NULL
beads	NULL
were	NULL
treated	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
thrombin	NULL
[	NULL
Sigma	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Beads	NULL
with	NULL
uncleaved	NULL
proteins	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
fresh	NULL
beads	NULL
to	NULL
remove	NULL
any	NULL
contaminating	NULL
uncleaved	NULL
proteins	NULL
.	NULL

In	NULL
vivo	NULL
protein	NULL
interaction	NULL
studies	NULL
Clone	NULL
DS19	NULL
MEL	NULL
cells	NULL
and	NULL
293	NULL
cells	NULL
were	NULL
grown	NULL
as	NULL
described	NULL
previously	NULL
[	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
by	NULL
Andrews	NULL
and	NULL
Faller	NULL
(	NULL
1991	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
lysis	NULL
of	NULL
nuclei	NULL
by	NULL
sonication	NULL
in	NULL
50	NULL
mm	NULL
HEPES	NULL
{	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
ECTA	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
protease	NULL
inhibitors	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
treating	NULL
cells	NULL
with	NULL
EBC	NULL
buffer	NULL
.	NULL

2983	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
with	NULL
pEBB	NULL
expression	NULL
vectors	NULL
{	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
]	NULL
encoding	NULL
PU.1	NULL
and	NULL
PU.1	NULL
mutants	NULL
and	NULL
pXM	NULL
expression	NULL
vectors	NULL
encoding	NULL
GATA-1	NULL
{	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
and	NULL
GATA-1	NULL
mutants	NULL
{	NULL
(	NULL
Martin	NULL
and	NULL
Orkin	NULL
1990	NULL
}	NULL
.	NULL

GATA-1	NULL
{	NULL
Afingers	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
pEBB	NULL
vector	NULL
.	NULL

Whole	NULL
cell	NULL
or	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
after	NULL
48	NULL
hr	NULL
as	NULL
above	NULL
.	NULL

Protein	NULL
concentrations	NULL
in	NULL
the	NULL
extracts	NULL
were	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
BioRad	NULL
)	NULL
.	NULL

MEL	NULL
cell	NULL
extracts	NULL
(	NULL
600	NULL
ug	NULL
)	NULL
and	NULL
298	NULL
cell	NULL
extracts	NULL
{	NULL
400	NULL
ug	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
immunoprecipitations	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
GATA-1	NULL
,	NULL
50	NULL
ul	NULL
of	NULL
Protein	NULL
A-Sepharose	NULL
beads	NULL
[	NULL
Pharmacia	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
8	NULL
ul	NULL
of	NULL
anti-GATA-1	NULL
antibody	NULL
N6	NULL
{	NULL
Santa	NULL
Cruz	NULL
)	NULL
and	NULL
2	NULL
ul	NULL
of	NULL
monoclonal	NULL
anti-rat	NULL
antibody	NULL
[	NULL
Sigma	NULL
)	NULL
overnight	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
8	NULL
ul	NULL
of	NULL
mouse	NULL
monoclonal	NULL
anti-p16	NULL
antibody	NULL
(	NULL
DCS-50.1/A7	NULL
;	NULL
NeoMarkers	NULL
)	NULL
and	NULL
2	NULL
ul	NULL
of	NULL
anti-rat	NULL
antibody	NULL
were	NULL
used	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
PU.1	NULL
,	NULL
50	NULL
ul	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
and	NULL
15	NULL
ul	NULL
of	NULL
anti-PU.1	NULL
antibody	NULL
T21	NULL
{	NULL
Santa	NULL
Cruz	NULL
)	NULL
or	NULL
15	NULL
pul	NULL
of	NULL
a	NULL
control	NULL
anti-cyclin	NULL
E	NULL
antibody	NULL
M-20	NULL
[	NULL
Santa	NULL
Cruz	NULL
]	NULL
were	NULL
used	NULL
.	NULL

Antibody-saturated	NULL
beads	NULL
were	NULL
collected	NULL
and	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
2	NULL
hr	NULL
.	NULL

Beads	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
and	NULL
bound	NULL
proteins	NULL
were	NULL
released	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
with	NULL
the	NULL
appropriate	NULL
antibodies	NULL
.	NULL

Transactivation	NULL
assays	NULL
NIH-3T3	NULL
and	NULL
Hela	NULL
cells	NULL
were	NULL
cultured	NULL
as	NULL
above	NULL
.	NULL

Twenty-four	NULL
hours	NULL
before	NULL
transfection	NULL
7	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
each	NULL
well	NULL
of	NULL
12-well	NULL
plates	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
Lipofectamine	NULL
Plus	NULL
method	NULL
{	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
%	NULL
serum	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
maintained	NULL
at	NULL
450	NULL
ng/well	NULL
by	NULL
adding	NULL
the	NULL
appropriated	NULL
amount	NULL
of	NULL
empty	NULL
pEBB	NULL
vector	NULL
DNA	NULL
.	NULL

Growth	NULL
hormone	NULL
production	NULL
was	NULL
measured	NULL
by	NULL
radioimmunoassay	NULL
{	NULL
Nichols	NULL
Institute	NULL
Di-agnostics	NULL
)	NULL
on	NULL
100	NULL
ul	NULL
[	NULL
10	NULL
%	NULL
]	NULL
of	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

Luciferase	NULL
production	NULL
was	NULL
measured	NULL
on	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
whole	NULL
cell	NULL
extracts	NULL
with	NULL
the	NULL
Promega	NULL
Luciferase	NULL
Assay	NULL
system	NULL
.	NULL

Constructs	NULL
used	NULL
in	NULL
the	NULL
reporter	NULL
assays	NULL
included	NULL
M1lo-GH	NULL
(	NULL
Martin	NULL
and	NULL
Orkin	NULL
1990	NULL
}	NULL
,	NULL
p45	NULL
NF-E2-CH	NULL
,	NULL
pMT2-FOG	NULL
(	NULL
Tsang	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
,	NULL
«	NULL
D3-LUC	NULL
{	NULL
Evans	NULL
and	NULL
Felsenfeld	NULL
1991	NULL
)	NULL
,	NULL
(	NULL
Watanabe	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
)	NULL
,	NULL
pEBB-PU.1	NULL
,	NULL
pEBB-AS-PU.1	NULL
{	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
]	NULL
,	NULL
pXM-GATA-1	NULL
and	NULL
SP6-GAL4-Spl	NULL
{	NULL
Sif	NULL
and	NULL
Gilmore	NULL
1994	NULL
)	NULL
.	NULL

Preparation	NULL
and	NULL
analysis	NULL
of	NULL
MEL	NULL
cell	NULL
stable	NULL
transfectants	NULL
MEL	NULL
cells	NULL
{	NULL
clone	NULL
DS19	NULL
}	NULL
or	NULL
cells	NULL
of	NULL
the	NULL
PU.1-MEL	NULL
transfectant	NULL
{	NULL
EFla-PU.1	NULL
clone	NULL
605	NULL
)	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
]	NULL
.	NULL

Selection	NULL
with	NULL
5	NULL
ug/ml	NULL
puromycin	NULL
{	NULL
MEL	NULL
}	NULL
or	NULL
5	NULL
ug/ml	NULL
puromycin	NULL
and	NULL
1	NULL
mg/ml	NULL
G418	NULL
{	NULL
clone	NULL
605	NULL
)	NULL
was	NULL
initiated	NULL
after	NULL
24	NULL
hr	NULL
.	NULL

Antibiotic-resistant	NULL
clones	NULL
were	NULL
expanded	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
.	NULL

Benzidine	NULL
staining	NULL
,	NULL
Northern	NULL
blot	NULL
hybridization	NULL
for	NULL
globin	NULL
mRNA	NULL
with	NULL
[	NULL
«	NULL
-°P	NULL
]	NULL
dCTP-labeled	NULL
pCA1l1	NULL
,	NULL
provided	NULL
by	NULL
W.	NULL
Zimmer	NULL
{	NULL
Univer-sity	NULL
of	NULL
South	NULL
Alabama	NULL
,	NULL
Mobile	NULL
}	NULL
,	NULL
and	NULL
plasma	NULL
clot	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
{	NULL
Rao	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
)	NULL
.	NULL

Expression	NULL
constructs	NULL
for	NULL
HA	NULL
epitope-tagged	NULL
PU.1	NULL
proteins	NULL
were	NULL
constructed	NULL
by	NULL
subcloning	NULL
PU.1	NULL
cDNA	NULL
fragments	NULL
into	NULL
a	NULL
modified	NULL
pEBB	NULL
vector	NULL
.	NULL

The	NULL
vector	NULL
pEBB-HA-puro	NULL
was	NULL
generated	NULL
by	NULL
blunt-end	NULL
ligation	NULL
of	NULL
the	NULL
Sall	NULL
fragment	NULL
of	NULL
pPGK-Puro	NULL
into	NULL
HindlII-digested	NULL
pEBB-HA	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
G.	NULL
Cheng	NULL
{	NULL
Uni-versity	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
}	NULL
.	NULL

PU.1-ATAD-HA	NULL
and	NULL
PU.1-APEST-HA	NULL
were	NULL
prepared	NULL
by	NULL
substitution	NULL
of	NULL
the	NULL
BarmI-KpnI	NULL
fragment	NULL
of	NULL
pEBB-PU.1-HA-puro	NULL
with	NULL
the	NULL
mutated	NULL
inserts	NULL
from	NULL
pBKS-ANN	NULL
and	NULL
pBSK-APEST	NULL
,	NULL
respectively	NULL
.	NULL

PU.1-ADBD-HA	NULL
was	NULL
created	NULL
by	NULL
digestion	NULL
of	NULL
PU.1-HA	NULL
with	NULL
KpnI	NULL
and	NULL
NotI	NULL
,	NULL
filling	NULL
in	NULL
with	NULL
Klenow	NULL
and	NULL
self-ligation	NULL
.	NULL

pEBB-GATA-1/ER-puro	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
GATA-1	NULL
/ER	NULL
into	NULL
the	NULL
pEBB-puro	NULL
vector	NULL
constructed	NULL
as	NULL
above	NULL
.	NULL

Immunoblotting	NULL
Proteins	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
were	NULL
transferred	NULL
to	NULL
nitrocel-lulose	NULL
or	NULL
PVDF	NULL
membranes	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
with	NULL
1:500	NULL
dilution	NULL
of	NULL
either	NULL
rat	NULL
monoclonal	NULL
anti-GATA-1	NULL
antibody	NULL
N6	NULL
or	NULL
1:5000	NULL
dilution	NULL
of	NULL
mouse	NULL
monoclonal	NULL
anti-HA	NULL
antibody	NULL
12CAS5	NULL
{	NULL
Boehringer	NULL
Mannheim	NULL
]	NULL
or	NULL
1:300	NULL
dilution	NULL
of	NULL
rabbit	NULL
polyclonal	NULL
anti-PU.1	NULL
antibody	NULL
T21	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
either	NULL
1:8000	NULL
dilution	NULL
of	NULL
HRP-conjugated	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Sigma	NULL
)	NULL
or	NULL
1:3500	NULL
dilution	NULL
of	NULL
HRP-conjugated	NULL
anti-rabbit	NULL
antibody	NULL
{	NULL
Santa	NULL
Cruz	NULL
)	NULL
.	NULL

HRP	NULL
activity	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
{	NULL
ECL	NULL
]	NULL
)	NULL
system	NULL
{	NULL
Amersham	NULL
}	NULL
.	NULL

Xenopus	NULL
embryos	NULL
and	NULL
explants	NULL
Xenopus	NULL
laevis	NULL
eggs	NULL
obtained	NULL
from	NULL
gonadotropin-induced	NULL
females	NULL
were	NULL
fertilized	NULL
in	NULL
vitro	NULL
.	NULL

Dejellied	NULL
embryos	NULL
were	NULL
placed	NULL
Interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
into	NULL
0.1x	NULL
MBS/5	NULL
%	NULL
Ficoll	NULL
solution	NULL
and	NULL
injected	NULL
with	NULL
4.5	NULL
pL	NULL
of	NULL
RNA	NULL
or	NULL
plasmid	NULL
solution	NULL
into	NULL
blastomeres	NULL
at	NULL
the	NULL
two-cell	NULL
stage	NULL
.	NULL

Alternatively	NULL
,	NULL
four-cell	NULL
stage	NULL
embryos	NULL
with	NULL
an	NULL
obvious	NULL
pigment	NULL
shift	NULL
and	NULL
precisely	NULL
oriented	NULL
cleavage	NULL
planes	NULL
were	NULL
chosen	NULL
to	NULL
target	NULL
injections	NULL
into	NULL
the	NULL
two	NULL
presumptive	NULL
ventral	NULL
blastomeres	NULL
.	NULL

Embryos	NULL
were	NULL
allowed	NULL
to	NULL
recover	NULL
for	NULL
several	NULL
hours	NULL
and	NULL
then	NULL
were	NULL
cultured	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
0.1x	NULL
MBS	NULL
.	NULL

Globin	NULL
production	NULL
was	NULL
analyzed	NULL
in	NULL
whole	NULL
embryos	NULL
by	NULL
benzidine	NULL
staining	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
when	NULL
the	NULL
dorsal	NULL
lip	NULL
was	NULL
first	NULL
visible	NULL
at	NULL
stage	NULL
10	NULL
1/4	NULL
,	NULL
VMZ	NULL
explants	NULL
were	NULL
cut	NULL
and	NULL
incubated	NULL
in	NULL
1x	NULL
MMR	NULL
for	NULL
56	NULL
hr	NULL
or	NULL
as	NULL
indicated	NULL
.	NULL

Protein	NULL
lysates	NULL
were	NULL
made	NULL
by	NULL
homogenizing	NULL
explants	NULL
in	NULL
10	NULL
pul	NULL
of	NULL
SDS	NULL
sample	NULL
buffer/explant	NULL
and	NULL
equal	NULL
ex-plant	NULL
equivalents	NULL
were	NULL
electrophoresed	NULL
in	NULL
17.5	NULL
%	NULL
acrylamide/	NULL
3m	NULL
urea	NULL
SDS	NULL
gels	NULL
before	NULL
blotting	NULL
.	NULL

The	NULL
14-26	NULL
mAb	NULL
specific	NULL
for	NULL
embryonic	NULL
«	NULL
-globin	NULL
chains	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
C.	NULL
Katagiri	NULL
.	NULL

HRP-conjugated	NULL
secondary	NULL
antibodies	NULL
were	NULL
detected	NULL
using	NULL
ECL	NULL
{	NULL
Amersham	NULL
}	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
murine	NULL
PU.1	NULL
or	NULL
Xenopus	NULL
GATA-1	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
SP64T	NULL
transcription	NULL
vector	NULL
and	NULL
mRNA	NULL
was	NULL
transcribed	NULL
in	NULL
vitro	NULL
using	NULL
SP6	NULL
polymerase	NULL
.	NULL

Control	NULL
RNAs	NULL
were	NULL
transcribed	NULL
from	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
PU.1	NULL
cDNA	NULL
in	NULL
the	NULL
reverse	NULL
orientation	NULL
{	NULL
PU.11rs	NULL
)	NULL
or	NULL
a	NULL
frameshift	NULL
mutant	NULL
form	NULL
of	NULL
the	NULL
GATA-1	NULL
cDNA	NULL
that	NULL
encoded	NULL
a	NULL
non-DNA-binding	NULL
truncated	NULL
iso-form	NULL
(	NULL
Glfs	NULL
]	NULL
.	NULL

RNA	NULL
was	NULL
quantified	NULL
by	NULL
UV	NULL
spectrometry	NULL
and	NULL
quality	NULL
was	NULL
analyzed	NULL
before	NULL
injection	NULL
by	NULL
gel	NULL
electrophoresis	NULL
and	NULL
in	NULL
vitro	NULL
translation	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
M.J.	NULL
Klemsz	NULL
,	NULL
S.H	NULL
.	NULL

Orkin	NULL
,	NULL
M.	NULL
Merika	NULL
,	NULL
and	NULL
G.A	NULL
.	NULL

Blobel	NULL
for	NULL
generously	NULL
providing	NULL
plasmids	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

T.E	NULL
.	NULL

thanks	NULL
T.	NULL
Torregroza	NULL
for	NULL
excellent	NULL
technical	NULL
help	NULL
.	NULL

A.L.S	NULL
.	NULL

receives	NULL
support	NULL
from	NULL
National	NULL
Cancer	NULL
Institute	NULL
Cancer	NULL
Center	NULL
grant	NULL
2P30CA13330	NULL
,	NULL
TE	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
{	NULL
NIH	NULL
)	NULL
{	NULL
HL56132	NULL
)	NULL
and	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
{	NULL
ACS	NULL
}	NULL
,	NULL
FR	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
NIH	NULL
5T32AGO0194	NULL
and	NULL
N.R	NULL
.	NULL

by	NULL
NIH	NULL
5T32GMO7491	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grant	NULL
5R37CA16368	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
'advertisement	NULL
'	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
USC	NULL
section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

References	NULL
Andrews	NULL
,	NULL
N.C.	NULL
and	NULL
D.V	NULL
.	NULL

Faller	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
rapid	NULL
micropreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
limiting	NULL
numbers	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleis	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
:	NULL
2499	NULL
.	NULL

Andrews	NULL
,	NULL
N.C.	NULL
,	NULL
K.J	NULL
.	NULL

Kotkow	NULL
,	NULL
P.A	NULL
.	NULL

Ney	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
ubiquitous	NULL
subunit	NULL
of	NULL
erythroid	NULL
transcription	NULL
factor	NULL
NF-E2	NULL
is	NULL
a	NULL
small	NULL
basic-leucine	NULL
zipper	NULL
protein	NULL
related	NULL
to	NULL
the	NULL
v-maf	NULL
oncogene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

90	NULL
:	NULL
11488-11492	NULL
.	NULL

Ben-David	NULL
,	NULL
Y.	NULL
and	NULL
A.	NULL
Bernstein	NULL
.	NULL

1991	NULL
.	NULL

Friend	NULL
virus-induced	NULL
erythroleukemia	NULL
and	NULL
the	NULL
multistage	NULL
nature	NULL
of	NULL
cancer	NULL
.	NULL

Cell	NULL
66	NULL
:	NULL
831-834	NULL
.	NULL

Ben-David	NULL
,	NULL
Y.	NULL
,	NULL
E.B	NULL
.	NULL

Giddens	NULL
,	NULL
K.	NULL
Letwin	NULL
,	NULL
and	NULL
A.	NULL
Bernstein	NULL
.	NULL

1991	NULL
.	NULL

Erythroleukemia	NULL
induction	NULL
by	NULL
Friend	NULL
murine	NULL
leukemia	NULL
vi-rus	NULL
:	NULL
Insertional	NULL
activation	NULL
of	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
ets	NULL
gene	NULL
family	NULL
,	NULL
Fli-1	NULL
,	NULL
closely	NULL
linked	NULL
to	NULL
c-ets-1	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
:	NULL
908-918	NULL
.	NULL

Blobel	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
C.A	NULL
.	NULL

Sieff	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1995	NULL
.	NULL

Ligand-dependent	NULL
repression	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
by	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1409	NULL
Rekhtman	NULL
et	NULL
al	NULL
.	NULL

the	NULL
estrogen	NULL
receptor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
3147-3153	NULL
.	NULL

Blobel	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
T.	NULL
Nakajima	NULL
,	NULL
R.	NULL
Eckner	NULL
,	NULL
M.	NULL
Montminy	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1998	NULL
.	NULL

CREB-binding	NULL
protein	NULL
cooperates	NULL
with	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
and	NULL
is	NULL
required	NULL
for	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

95	NULL
:	NULL
2061-2066	NULL
.	NULL

Borras	NULL
,	NULL
F.E	NULL
.	NULL

,	NULL
J.	NULL
Lloberas	NULL
,	NULL
R.A.	NULL
Maki	NULL
,	NULL
and	NULL
A.	NULL
Celada	NULL
.	NULL

1995	NULL
.	NULL

Repression	NULL
of	NULL
I-A	NULL
beta	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
PU.1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
24385-24391	NULL
.	NULL

Briegel	NULL
,	NULL
K.	NULL
,	NULL
K.C	NULL
.	NULL

Lim	NULL
,	NULL
C.	NULL
Plank	NULL
,	NULL
H.	NULL
Beug	NULL
,	NULL
J.D	NULL
.	NULL

Engel	NULL
,	NULL
and	NULL
M.	NULL
Zenke	NULL
.	NULL

1993	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
a	NULL
conditional	NULL
GATA-2/	NULL
estrogen	NULL
receptor	NULL
chimera	NULL
arrests	NULL
erythroid	NULL
differentiation	NULL
in	NULL
a	NULL
hormone-dependent	NULL
manner	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7:1097-1109	NULL
.	NULL

Cheng	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shen	NULL
,	NULL
D.	NULL
Giokas	NULL
,	NULL
J.	NULL
Gere	NULL
,	NULL
D.G	NULL
.	NULL

Tenen	NULL
,	NULL
and	NULL
D.T	NULL
.	NULL

Scadden	NULL
.	NULL

1996	NULL
.	NULL

Temporal	NULL
mapping	NULL
of	NULL
gene	NULL
expression	NULL
levels	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
individual	NULL
primary	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

93	NULL
:	NULL
13158-13163	NULL
.	NULL

Cross	NULL
,	NULL
M.A	NULL
.	NULL

and	NULL
T.	NULL
Enver	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
lineage	NULL
commitment	NULL
of	NULL
haemopoietic	NULL
progenitor	NULL
cells	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

7	NULL
:	NULL
609-613	NULL
.	NULL

Delgado	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
P.	NULL
Gutierrez	NULL
,	NULL
C.	NULL
Richard	NULL
,	NULL
M.A	NULL
.	NULL

Cuadrado	NULL
,	NULL
F.	NULL
Moreau-Gachelin	NULL
,	NULL
and	NULL
J.	NULL
Leon	NULL
.	NULL

1998	NULL
.	NULL

Spi-1/PU.1	NULL
proto-onco-gene	NULL
induces	NULL
opposite	NULL
effects	NULL
on	NULL
monocytic	NULL
and	NULL
erythroid	NULL
differentiation	NULL
of	NULL
K562	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

252	NULL
:	NULL
383-391	NULL
.	NULL

Evans	NULL
,	NULL
T.	NULL
and	NULL
G.	NULL
Felsenfeld	NULL
.	NULL

1991	NULL
.	NULL

Trans-Activation	NULL
of	NULL
a	NULL
globin	NULL
promoter	NULL
in	NULL
nonerythroid	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
843-853	NULL
.	NULL

Fisher	NULL
,	NULL
R.C	NULL
.	NULL

and	NULL
E.W	NULL
.	NULL

Scott	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
PU.1	NULL
in	NULL
hematopoiesis	NULL
.	NULL

Stem	NULL
Cells	NULL
16:1	NULL
25-37	NULL
.	NULL

Galson	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
J.O0	NULL
.	NULL

Hensold	NULL
,	NULL
TR	NULL
.	NULL

Bishop	NULL
,	NULL
M.	NULL
Schalling	NULL
,	NULL
A.D.	NULL
D'Andrea	NULL
,	NULL
C.	NULL
Jones	NULL
,	NULL
P.E	NULL
.	NULL

Auron	NULL
,	NULL
and	NULL
D.E	NULL
.	NULL

Housman	NULL
.	NULL

1993	NULL
.	NULL

Mouse	NULL
beta-globin	NULL
DNA-binding	NULL
protein	NULL
Bl	NULL
is	NULL
identical	NULL
to	NULL
a	NULL
proto-oncogene	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
,	NULL
and	NULL
is	NULL
restricted	NULL
in	NULL
expression	NULL
to	NULL
hematopoietic	NULL
cells	NULL
and	NULL
the	NULL
testis	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
2929-2941	NULL
.	NULL

Gauthier	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
B.	NULL
Bourachot	NULL
,	NULL
V.	NULL
Doucas	NULL
,	NULL
M.	NULL
Yaniv	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1993	NULL
.	NULL

Functional	NULL
interference	NULL
between	NULL
the	NULL
Spi-1/PU.1	NULL
oncoprotein	NULL
and	NULL
steroid	NULL
hormone	NULL
or	NULL
vitamin	NULL
receptors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12	NULL
:	NULL
5089-5096	NULL
.	NULL

Goebl	NULL
,	NULL
M.K	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
PU.1	NULL
transcription	NULL
factor	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
putative	NULL
oncogene	NULL
Spi-1	NULL
.	NULL

Cell	NULL
61	NULL
:	NULL
1165-1166	NULL
.	NULL

Haenlin	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Cubadda	NULL
,	NULL
F.	NULL
Blondeau	NULL
,	NULL
P.	NULL
Heitzler	NULL
,	NULL
Y.	NULL
Lutz	NULL
,	NULL
P.	NULL
Simpson	NULL
,	NULL
and	NULL
P.	NULL
Ramain	NULL
.	NULL

1997	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
Pannier	NULL
is	NULL
regulated	NULL
negatively	NULL
by	NULL
heterodimerization	NULL
of	NULL
the	NULL
GATA	NULL
DNA-binding	NULL
domain	NULL
with	NULL
a	NULL
cofactor	NULL
encoded	NULL
by	NULL
the	NULL
u-shaped	NULL
gene	NULL
of	NULL
Drosophila	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

11	NULL
:	NULL
3096-3108	NULL
.	NULL

Hagemeier	NULL
,	NULL
C.	NULL
,	NULL
A.J	NULL
.	NULL

Bannister	NULL
,	NULL
A.	NULL
Cook	NULL
,	NULL
and	NULL
T.	NULL
Kouzarides	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
activation	NULL
domain	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
binds	NULL
the	NULL
retinoblastoma	NULL
{	NULL
RB	NULL
)	NULL
protein	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
TFIID	NULL
in	NULL
vitro	NULL
:	NULL
RB	NULL
shows	NULL
sequence	NULL
similarity	NULL
to	NULL
TFIID	NULL
and	NULL
TFIIB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

90	NULL
:	NULL
1580-1584	NULL
.	NULL

Hallier	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
binds	NULL
RNA	NULL
and	NULL
interferes	NULL
with	NULL
the	NULL
RNA-binding	NULL
protein	NULL
p54nrb	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
11177-11181	NULL
.	NULL

Hallier	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Lerga	NULL
,	NULL
S.	NULL
Barnache	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
interacts	NULL
with	NULL
the	NULL
potential	NULL
splicing	NULL
factor	NULL
TLS	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2731	NULL
4838-4842	NULL
.	NULL

Henkel	NULL
,	NULL
G.	NULL
and	NULL
M.A	NULL
.	NULL

Brown	NULL
.	NULL

1994	NULL
.	NULL

PU.1	NULL
and	NULL
GATA	NULL
:	NULL
Components	NULL
of	NULL
a	NULL
mast	NULL
cell-specific	NULL
interleukin	NULL
4	NULL
intronic	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

911	NULL
7737-7741	NULL
.	NULL

Hromas	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Orazi	NULL
,	NULL
R.S	NULL
.	NULL

Neiman	NULL
,	NULL
R.	NULL
Maki	NULL
,	NULL
C.	NULL
Van	NULL
Beveran	NULL
,	NULL
J.	NULL
Moore	NULL
,	NULL
and	NULL
M.	NULL
Klemsz	NULL
.	NULL

1993	NULL
.	NULL

Hematopoietic	NULL
lineage-	NULL
and	NULL
stage-restricted	NULL
expression	NULL
of	NULL
the	NULL
ETS	NULL
oncogene	NULL
family	NULL
member	NULL
PU.1	NULL
.	NULL

Blood	NULL
82	NULL
:	NULL
2998-3004	NULL
.	NULL

1410	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
Hunter	NULL
,	NULL
T.	NULL
1997	NULL
.	NULL

Oncoprotein	NULL
networks	NULL
.	NULL

Cell	NULL
88	NULL
:	NULL
333-346	NULL
.	NULL

Klemsz	NULL
,	NULL
M.J.	NULL
and	NULL
R.A.	NULL
Maki	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
PU.1	NULL
requires	NULL
both	NULL
acidic	NULL
and	NULL
glutamine	NULL
domains	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
:	NULL
390-397	NULL
.	NULL

Klemsz	NULL
,	NULL
M.J.	NULL
,	NULL
S.R	NULL
.	NULL

McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
and	NULL
R.A.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
61	NULL
:	NULL
113-124	NULL
.	NULL

Krieg	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
D.A	NULL
.	NULL

Melton	NULL
.	NULL

1987	NULL
.	NULL

In	NULL
vitro	NULL
RNA	NULL
synthesis	NULL
with	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

155	NULL
:	NULL
397-415	NULL
.	NULL

Leonard	NULL
,	NULL
M.W	NULL
.	NULL

,	NULL
K.C	NULL
.	NULL

Lim	NULL
,	NULL
and	NULL
J.D	NULL
.	NULL

Engel	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
chicken	NULL
GATA	NULL
factor	NULL
family	NULL
during	NULL
early	NULL
erythroid	NULL
development	NULL
and	NULL
differentiation	NULL
.	NULL

Development	NULL
119	NULL
:	NULL
519-531	NULL
.	NULL

Look	NULL
,	NULL
A.T.	NULL
1997	NULL
.	NULL

Oncogenic	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
human	NULL
acute	NULL
leukemias	NULL
.	NULL

Science	NULL
278	NULL
:	NULL
1059-1064	NULL
.	NULL

Lopez-Rodriguez	NULL
,	NULL
C.	NULL
and	NULL
A.L	NULL
.	NULL

Corbi	NULL
.	NULL

1997	NULL
.	NULL

PU.1	NULL
negatively	NULL
regulates	NULL
the	NULL
CD11c	NULL
integrin	NULL
gene	NULL
promoter	NULL
through	NULL
recognition	NULL
of	NULL
the	NULL
major	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

271	NULL
1843-1847	NULL
.	NULL

Lu	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
S.	NULL
Rowan	NULL
,	NULL
M.R	NULL
.	NULL

Bani	NULL
,	NULL
and	NULL
Y.	NULL
Ben-David	NULL
.	NULL

1994	NULL
.	NULL

Retrovi-ral	NULL
integration	NULL
within	NULL
the	NULL
FIi-2	NULL
locus	NULL
results	NULL
in	NULL
inactivation	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
NF-E2	NULL
in	NULL
Friend	NULL
eryth-roleukemias	NULL
:	NULL
Evidence	NULL
that	NULL
NF-E2	NULL
is	NULL
essential	NULL
for	NULL
globin	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

91	NULL
:	NULL
8398-8402	NULL
.	NULL

Marks	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
M.	NULL
Sheffery	NULL
,	NULL
and	NULL
R.A.	NULL
Rifkind	NULL
.	NULL

1987	NULL
.	NULL

Induction	NULL
of	NULL
transformed	NULL
cells	NULL
to	NULL
terminal	NULL
differentiation	NULL
and	NULL
the	NULL
modulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

47	NULL
:	NULL
659-666	NULL
.	NULL

Martin	NULL
,	NULL
D.I	NULL
.	NULL

and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
activation	NULL
and	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
erythroid	NULL
factor	NULL
GF-	NULL
1	NULL
/NF-E1/Eryf	NULL
1	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
:	NULL
1886-1898	NULL
.	NULL

McKercher	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
B.E	NULL
.	NULL

Torbett	NULL
,	NULL
K.L	NULL
.	NULL

Anderson	NULL
,	NULL
G.	NULL
W.	NULL
Henkel	NULL
,	NULL
DJ	NULL
.	NULL

Vestal	NULL
,	NULL
H.	NULL
Baribault	NULL
,	NULL
M.	NULL
Klemsz	NULL
,	NULL
A.J	NULL
.	NULL

Feeney	NULL
,	NULL
G.E	NULL
.	NULL

Wu	NULL
,	NULL
C.J	NULL
.	NULL

Paige	NULL
,	NULL
and	NULL
R.A.	NULL
Maki	NULL
.	NULL

1996	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
gene	NULL
results	NULL
in	NULL
multiple	NULL
hematopoietic	NULL
abnormalities	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

151	NULL
5647-5658	NULL
.	NULL

Merika	NULL
,	NULL
M.	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
synergy	NULL
and	NULL
physical	NULL
interactions	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
with	NULL
the	NULL
Kruppel	NULL
family	NULL
proteins	NULL
Spl	NULL
and	NULL
EKLF	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
2437-2447	NULL
.	NULL

Miller	NULL
,	NULL
LJ	NULL
.	NULL

and	NULL
J.J.	NULL
Bieker	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
novel	NULL
,	NULL
erythroid	NULL
cell-specific	NULL
murine	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
CACCC	NULL
element	NULL
and	NULL
is	NULL
related	NULL
to	NULL
the	NULL
Kruppel	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
2776-2786	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
1994	NULL
.	NULL

Spi-1/PU.1	NULL
:	NULL
An	NULL
oncogene	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1198	NULL
:	NULL
149-168	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
P.	NULL
Tambourin	NULL
.	NULL

1988	NULL
.	NULL

Spi-1	NULL
is	NULL
a	NULL
putative	NULL
oncogene	NULL
in	NULL
virally	NULL
induced	NULL
murine	NULL
eryth-roleukaemias	NULL
.	NULL

Nature	NULL
331	NULL
:	NULL
277-280	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Ray	NULL
,	NULL
M.G	NULL
.	NULL

Mattei	NULL
,	NULL
P.	NULL
Tambourin	NULL
,	NULL
and	NULL
A.	NULL
Tavitian	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
putative	NULL
oncogene	NULL
Spi-l	NULL
:	NULL
Murine	NULL
chromosomal	NULL
localization	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
murine	NULL
acute	NULL
erythroleukemias	NULL
.	NULL

Oncogene	NULL
4	NULL
:	NULL
1449-1456	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
F.	NULL
Wendling	NULL
,	NULL
T.	NULL
Molina	NULL
,	NULL
N.	NULL
Denis	NULL
,	NULL
M.	NULL
Tit-eux	NULL
,	NULL
G.	NULL
Grimber	NULL
,	NULL
P.	NULL
Briand	NULL
,	NULL
W.	NULL
Vainchenker	NULL
,	NULL
and	NULL
A.	NULL
Tavitian	NULL
.	NULL

1996	NULL
.	NULL

Spi-1/PU.1	NULL
transgenic	NULL
mice	NULL
develop	NULL
multistep	NULL
erythroleukemias	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
:	NULL
2453-2463	NULL
.	NULL

Nagulapalli	NULL
,	NULL
S.	NULL
,	NULL
J.M	NULL
.	NULL

Pongubala	NULL
,	NULL
and	NULL
ML	NULL
.	NULL

Atchison	NULL
.	NULL

1995	NULL
.	NULL

Multiple	NULL
proteins	NULL
physically	NULL
interact	NULL
with	NULL
PU.1	NULL
.	NULL

Transcriptional	NULL
synergy	NULL
with	NULL
NF-IL6	NULL
beta	NULL
{	NULL
C/EBP	NULL
delta	NULL
,	NULL
CRP3	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155	NULL
:	NULL
4330-4338	NULL
.	NULL

Nemoto	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Terajima	NULL
,	NULL
W.	NULL
Shoji	NULL
,	NULL
and	NULL
M.	NULL
Obinata	NULL
.	NULL

1996	NULL
.	NULL

Regulatory	NULL
function	NULL
of	NULL
delta/YY-1	NULL
on	NULL
the	NULL
locus	NULL
control	NULL
re-gion-like	NULL
sequence	NULL
of	NULL
mouse	NULL
glycophorin	NULL
gene	NULL
in	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
13542-18548	NULL
.	NULL

Nerlov	NULL
,	NULL
C.	NULL
and	NULL
T.	NULL
Graf	NULL
.	NULL

1998	NULL
.	NULL

PU.1	NULL
induces	NULL
myeloid	NULL
lineage	NULL
commitment	NULL
in	NULL
multipotent	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

12	NULL
:	NULL
2403-2412	NULL
.	NULL

Osada	NULL
,	NULL
H.	NULL
,	NULL
G.	NULL
Grutz	NULL
,	NULL
H.	NULL
Axelson	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
and	NULL
TH	NULL
.	NULL

Rabbitts	NULL
.	NULL

1995	NULL
.	NULL

Association	NULL
of	NULL
erythroid	NULL
transcription	NULL
factors	NULL
:	NULL
Complexes	NULL
involving	NULL
the	NULL
LIM	NULL
protein	NULL
RBTN2	NULL
and	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
GATA1L	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

921	NULL
9585-9589	NULL
.	NULL

Paul	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Schuetze	NULL
,	NULL
S.L	NULL
.	NULL

Kozak	NULL
,	NULL
and	NULL
D.	NULL
Kabat	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
common	NULL
site	NULL
for	NULL
immortalizing	NULL
proviral	NULL
integrations	NULL
in	NULL
Friend	NULL
erythroleukemia	NULL
:	NULL
Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63	NULL
:	NULL
4958-4961	NULL
.	NULL

Petrovick	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
SW.	NULL
Hiebert	NULL
,	NULL
A.D.	NULL
Friedman	NULL
,	NULL
C.J	NULL
.	NULL

Hethering-ton	NULL
,	NULL
D.G	NULL
.	NULL

Tenen	NULL
,	NULL
and	NULL
D.E	NULL
.	NULL

Zhang	NULL
.	NULL

1998	NULL
.	NULL

Multiple	NULL
functional	NULL
domains	NULL
of	NULL
AML1	NULL
:	NULL
PU.1	NULL
and	NULL
C/EBPalpha	NULL
synergize	NULL
with	NULL
different	NULL
regions	NULL
of	NULL
AML1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
:	NULL
3915-3925	NULL
.	NULL

Quang	NULL
,	NULL
C.T	NULL
.	NULL

,	NULL
M.	NULL
Pironin	NULL
,	NULL
M.	NULL
von	NULL
Lindern	NULL
,	NULL
H.	NULL
Beug	NULL
,	NULL
and	NULL
J.	NULL
Ghys-dael	NULL
.	NULL

1995	NULL
.	NULL

Spi-1	NULL
and	NULL
mutant	NULL
p53	NULL
regulate	NULL
different	NULL
aspects	NULL
of	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
control	NULL
of	NULL
primary	NULL
erythroid	NULL
progenitors	NULL
.	NULL

Oncogene	NULL
11	NULL
:	NULL
1229-1239	NULL
.	NULL

Rao	NULL
,	NULL
G.	NULL
,	NULL
N.	NULL
Rekhtman	NULL
,	NULL
G.	NULL
Cheng	NULL
,	NULL
T.	NULL
Krasikov	NULL
,	NULL
and	NULL
ALI	NULL
.	NULL

Skoult-chi	NULL
.	NULL

1997	NULL
.	NULL

Deregulated	NULL
expression	NULL
of	NULL
the	NULL
PU.1	NULL
transcription	NULL
factor	NULL
blocks	NULL
murine	NULL
erythroleukemia	NULL
cell	NULL
terminal	NULL
differentiation	NULL
.	NULL

Oncogene	NULL
14	NULL
:	NULL
123-131	NULL
.	NULL

Ray	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
M.G	NULL
.	NULL

Mattei	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
Spi-B	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
putative	NULL
oncoprotein	NULL
Spi-1/	NULL
PU.1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
;	NULL
4297-4304	NULL
.	NULL

Reddy	NULL
,	NULL
P.M.	NULL
and	NULL
C.K	NULL
.	NULL

Shen	NULL
.	NULL

19983	NULL
.	NULL

Erythroid	NULL
differentiation	NULL
of	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
results	NULL
in	NULL
reorganization	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
the	NULL
mouse	NULL
beta	NULL
major	NULL
globin	NULL
promoter	NULL
but	NULL
not	NULL
its	NULL
distal	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
1093-1103	NULL
.	NULL

Schuetze	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Paul	NULL
,	NULL
B.C	NULL
.	NULL

Gliniak	NULL
,	NULL
and	NULL
D.	NULL
Kabat	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
PU.1	NULL
transcription	NULL
factor	NULL
in	NULL
controlling	NULL
differentiation	NULL
of	NULL
Friend	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

12	NULL
:	NULL
2967-2975	NULL
.	NULL

Schuetze	NULL
,	NULL
S.	NULL
,	NULL
P.E	NULL
.	NULL

Stenberg	NULL
,	NULL
and	NULL
D.	NULL
Kabat	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
PU.1	NULL
immortalizes	NULL
erythroblasts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
5670-5678	NULL
.	NULL

Scott	NULL
,	NULL
EW	NULL
.	NULL

,	NULL
M.C	NULL
.	NULL

Simon	NULL
,	NULL
J.	NULL
Anastasi	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1994	NULL
.	NULL

Requirement	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
development	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Science	NULL
265	NULL
:	NULL
1573-1577	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.A.	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
transcriptional	NULL
control	NULL
of	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
87	NULL
:	NULL
4025-4039	NULL
.	NULL

Sif	NULL
,	NULL
S.	NULL
and	NULL
TD	NULL
.	NULL

Gilmore	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
v-Rel	NULL
oncoprotein	NULL
with	NULL
cellular	NULL
transcription	NULL
factor	NULL
Spl	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68	NULL
:	NULL
7131-7138	NULL
.	NULL

Starck	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Doubeikovski	NULL
,	NULL
S.	NULL
Sarrazin	NULL
,	NULL
C.	NULL
Gonnet	NULL
,	NULL
G.	NULL
Rao	NULL
,	NULL
A.	NULL
Skoultchi	NULL
,	NULL
J.	NULL
Godet	NULL
,	NULL
I.	NULL
Dusanter-Fourt	NULL
,	NULL
and	NULL
F.	NULL
Morle	NULL
.	NULL

1999	NULL
.	NULL

Spi-1	NULL
/PU.1	NULL
is	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
the	NULL
fli-1	NULL
gene	NULL
involved	NULL
in	NULL
inhibition	NULL
of	NULL
erythroid	NULL
differentiation	NULL
in	NULL
friend	NULL
erythroleu-kemic	NULL
cell	NULL
lines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19	NULL
:	NULL
121-135	NULL
.	NULL

Strauss	NULL
,	NULL
E.C	NULL
.	NULL

,	NULL
N.C.	NULL
Andrews	NULL
,	NULL
D.R	NULL
.	NULL

Higgs	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
human	NULL
alpha-globin	NULL
locus	NULL
upstream	NULL
regulatory	NULL
element	NULL
by	NULL
guanine	NULL
and	NULL
adenine	NULL
ligation-mediated	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
:	NULL
2135-2142	NULL
.	NULL

Tenen	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
R.	NULL
Hromas	NULL
,	NULL
J.D	NULL
.	NULL

Licht	NULL
,	NULL
and	NULL
D.E	NULL
.	NULL

Zhang	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factors	NULL
,	NULL
normal	NULL
myeloid	NULL
development	NULL
,	NULL
and	NULL
leuke-mia	NULL
.	NULL

Blood	NULL
90	NULL
:	NULL
489-519	NULL
.	NULL

Tsai	NULL
,	NULL
F.Y	NULL
.	NULL

,	NULL
G.	NULL
Keller	NULL
,	NULL
F.C	NULL
.	NULL

Kuo	NULL
,	NULL
M.	NULL
Weiss	NULL
,	NULL
J.	NULL
Chen	NULL
,	NULL
M.	NULL
Rosenblatt	NULL
,	NULL
FW	NULL
.	NULL

Alt	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1994	NULL
.	NULL

An	NULL
early	NULL
haematopoietic	NULL
defect	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-2	NULL
.	NULL

Nature	NULL
371	NULL
:	NULL
221-226	NULL
.	NULL

Tsai	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
D.I	NULL
.	NULL

Martin	NULL
,	NULL
LI	NULL
.	NULL

Zon	NULL
,	NULL
A.D.	NULL
D'Andrea	NULL
,	NULL
G.G	NULL
.	NULL

Wong	NULL
,	NULL
and	NULL
SH	NULL
.	NULL

Orkin	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
of	NULL
cDNA	NULL
for	NULL
the	NULL
major	NULL
DNA-binding	NULL
protein	NULL
of	NULL
the	NULL
erythroid	NULL
lineage	NULL
through	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nature	NULL
339	NULL
:	NULL
446-451	NULL
.	NULL

Interaction	NULL
of	NULL
PU.1	NULL
and	NULL
GATA-1	NULL
Tsang	NULL
,	NULL
A.P	NULL
.	NULL

,	NULL
J.E	NULL
.	NULL

Visvader	NULL
,	NULL
C.A	NULL
.	NULL

Turner	NULL
,	NULL
Y.	NULL
Fujiwara	NULL
,	NULL
C.	NULL
Yu	NULL
,	NULL
MJ	NULL
.	NULL

Weiss	NULL
,	NULL
M.	NULL
Crossley	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1997	NULL
.	NULL

FOG	NULL
,	NULL
a	NULL
multitype	NULL
zinc	NULL
finger	NULL
protein	NULL
,	NULL
acts	NULL
as	NULL
a	NULL
cofactor	NULL
for	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
in	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
differentiation	NULL
.	NULL

Cell	NULL
90	NULL
:	NULL
109-119	NULL
.	NULL

Watanabe	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Howe	NULL
,	NULL
R.J.	NULL
Lee	NULL
,	NULL
C.	NULL
Albanese	NULL
,	NULL
LW	NULL
.	NULL

Shu	NULL
,	NULL
A.N	NULL
.	NULL

Karnezis	NULL
,	NULL
L.	NULL
Zon	NULL
,	NULL
J.	NULL
Kyriakis	NULL
,	NULL
K.	NULL
Rundell	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Pestell	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
cyelin	NULL
D1	NULL
by	NULL
simian	NULL
virus	NULL
40	NULL
small	NULL
tumor	NULL
antigen	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

93	NULL
:	NULL
12861-12866	NULL
.	NULL

Weintraub	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
KN	NULL
.	NULL

Chow	NULL
,	NULL
RX	NULL
.	NULL

Luo	NULL
,	NULL
S.H	NULL
.	NULL

Zhang	NULL
,	NULL
S.	NULL
He	NULL
,	NULL
and	NULL
D.C.	NULL
Dean	NULL
.	NULL

1995	NULL
.	NULL

Mechanism	NULL
of	NULL
active	NULL
transcriptional	NULL
repression	NULL
by	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Nature	NULL
375	NULL
:	NULL
812-815	NULL
.	NULL

Yamada	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Kondoh	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
A.	NULL
Maekawa	NULL
,	NULL
and	NULL
T.	NULL
Oikawa	NULL
.	NULL

1997	NULL
.	NULL

Overexpression	NULL
of	NULL
PU.1	NULL
induces	NULL
growth	NULL
and	NULL
differentiation	NULL
inhibition	NULL
and	NULL
apoptotic	NULL
cell	NULL
death	NULL
in	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Blood	NULL
89	NULL
:	NULL
1383-1393	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
1411	NULL

